Pub-Med citations re marijuana – June 2021

This message contains search results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).

 

1. Cannabis.

[No authors listed]

2021 Jun 21. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–.

PMID: 30000647 Free Books & Documents. Review.

2. Review of the Endocannabinoid System.

Lu HC, Mackie K.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Jun;6(6):607-615. doi: 10.1016/j.bpsc.2020.07.016. Epub 2020 Aug 1.

PMID: 32980261 Review.

3. Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial.

Ruberto AJ, Sivilotti MLA, Forrester S, Hall AK, Crawford FM, Day AG.

Ann Emerg Med. 2021 Jun;77(6):613-619. doi: 10.1016/j.annemergmed.2020.08.021. Epub 2020 Nov 5.

PMID: 33160719

4. Self-reported driving after marijuana use in association with medical and recreational marijuana policies.

Benedetti MH, Li L, Neuroth LM, Humphries KD, Brooks-Russell A, Zhu M.

Int J Drug Policy. 2021 Jun;92:102944. doi: 10.1016/j.drugpo.2020.102944. Epub 2020 Oct 22.

PMID: 33268196

5. Cannabis and Cannabinoids (PDQ®): Health Professional Version.

PDQ Integrative, Alternative, and Complementary Therapies Editorial Board.

2021 Jun 3. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–.

PMID: 26389198 Free Books & Documents. Review.

6. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials.

Fisher E, Moore RA, Fogarty AE, Finn DP, Finnerup NB, Gilron I, Haroutounian S, Krane E, Rice ASC, Rowbotham M, Wallace M, Eccleston C.

Pain. 2021 Jul 1;162(Suppl 1):S45-S66. doi: 10.1097/j.pain.0000000000001929.

PMID: 32804836

7. Use of Cannabis and Cannabinoids in Patients With Cancer.

Sawtelle L, Holle LM.

Ann Pharmacother. 2021 Jul;55(7):870-890. doi: 10.1177/1060028020965224. Epub 2020 Oct 17.

PMID: 33070617

8. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence.

Chye Y, Kirkham R, Lorenzetti V, McTavish E, Solowij N, Yücel M.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Jun;6(6):627-635. doi: 10.1016/j.bpsc.2020.07.009. Epub 2020 Jul 21.

PMID: 32948510 Review.

9. Cumulative Marijuana Use and Carotid Intima-Media Thickness at Middle Age: The CARDIA Study.

Jakob J, von Wyl R, Stalder O, Pletcher MJ, Vittinghoff E, Tal K, Rana JS, Sidney S, Reis JP, Auer R.

Am J Med. 2021 Jun;134(6):777-787.e9. doi: 10.1016/j.amjmed.2020.11.026. Epub 2020 Dec 24.

PMID: 33359272

10. Marijuana use/nonuse among those aged 50+: comparisons of use-to-nonuse, initiation/reinitiation, and continued use over 24 months.

Choi NG, DiNitto DM.

Aging Ment Health. 2021 Jun;25(6):1134-1142. doi: 10.1080/13607863.2020.1732292. Epub 2020 Mar 2.

PMID: 32114789

11. Substance use in youth at-risk for serious mental illness.

Farris MS, Shakeel MK, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J.

Early Interv Psychiatry. 2021 Jun;15(3):634-641. doi: 10.1111/eip.12995. Epub 2020 Jun 4.

PMID: 32500614

12. Differences in Substance Use and Sexual Risk by Sexual Orientation and Gender Identity Among University and Community Young Adults in a U.S.-Mexico Border City.

Loza O, Mangadu T, Ferreira-Pinto JB, Guevara P.

Health Promot Pract. 2021 Jul;22(4):559-573. doi: 10.1177/1524839920933257. Epub 2020 Jun 15.

PMID: 32536322

13. Mental Health, Physical Health, and Cultural Characteristics Among American Indians/Alaska Natives Seeking Substance Use Treatment in an Urban Setting: A Descriptive Study.

Dickerson DL, D’Amico EJ, Klein DJ, Johnson CL, Hale B, Ye F.

Community Ment Health J. 2021 Jul;57(5):937-947. doi: 10.1007/s10597-020-00688-3. Epub 2020 Jul 27.

PMID: 32720004

14. The relationships between marijuana use and exercise among young and middle-aged adults.

French MT, Mortensen K, Kovalski MA.

Prev Med. 2021 Jun;147:106518. doi: 10.1016/j.ypmed.2021.106518. Epub 2021 Mar 9.

PMID: 33711350

15. Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre.

Robson H, Braund R, Glass M, Ashton J, Tatley M.

Clin Toxicol (Phila). 2021 Jun;59(6):472-479. doi: 10.1080/15563650.2020.1828592. Epub 2020 Nov 6.

PMID: 33156704

16. The key role of mass spectrometry in comprehensive research on new psychoactive substances.

Fabregat-Safont D, Sancho JV, Hernández F, Ibáñez M.

J Mass Spectrom. 2021 Jul;56(7):e4673. doi: 10.1002/jms.4673. Epub 2020 Nov 5.

PMID: 33155376

17. Neighborhood Disorder and Risk-Taking Among Justice-Involved Youth-The Mediating Role of Life Expectancy.

Kan E, Knowles A, Peniche M, Frick PJ, Steinberg L, Cauffman E.

J Res Adolesc. 2021 Jun;31(2):282-298. doi: 10.1111/jora.12596. Epub 2020 Nov 24.

PMID: 33232554

18. Serum per- and polyfluoroalkyl substance (PFAS) concentrations and predictors of exposure among pregnant African American women in the Atlanta area, Georgia.

Chang CJ, Ryan PB, Smarr MM, Kannan K, Panuwet P, Dunlop AL, Corwin EJ, Barr DB.

Environ Res. 2021 Jul;198:110445. doi: 10.1016/j.envres.2020.110445. Epub 2020 Nov 10.

PMID: 33186575

19. A novel approach to assess descriptive and injunctive norms for college student marijuana use.

Montes KS, Richards DK, Pearson MR; Marijuana Outcomes Study Team.

Addict Behav. 2021 Jun;117:106755. doi: 10.1016/j.addbeh.2020.106755. Epub 2020 Dec 2.

PMID: 33556670

20. Extrusion improves the phenolic profile and biological activities of hempseed (Cannabis sativa L.) hull.

Leonard W, Zhang P, Ying D, Xiong Y, Fang Z.

Food Chem. 2021 Jun 1;346:128606. doi: 10.1016/j.foodchem.2020.128606. Epub 2020 Nov 13.

PMID: 33388667

21. The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ9-Tetrahydrocannabinol and Cannabidiol.

Gunasekera B, Davies C, Martin-Santos R, Bhattacharyya S.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Jun;6(6):636-645. doi: 10.1016/j.bpsc.2020.10.007. Epub 2020 Oct 27.

PMID: 33414100 Review.

22. Virtual raves and happy hours during COVID-19: New drug use contexts for electronic dance music partygoers.

Palamar JJ, Acosta P.

Int J Drug Policy. 2021 Jul;93:102904. doi: 10.1016/j.drugpo.2020.102904. Epub 2020 Aug 26.

PMID: 32861536 Free PMC article.

23. Using measured cannabidiol and tetrahydrocannabinol metabolites in urine to differentiate marijuana use from consumption of commercial cannabidiol products.

Goggin MM, Janis GC.

Clin Toxicol (Phila). 2021 Jun;59(6):506-514. doi: 10.1080/15563650.2020.1827148. Epub 2020 Oct 29.

PMID: 33118434

24. Synthetic cannabinoid induced ocular self-injury.

Malik K, Kommana S, Paul J, Krakauer M.

Orbit. 2021 Aug;40(4):326-328. doi: 10.1080/01676830.2020.1781199. Epub 2020 Jun 18.

PMID: 32552411

25. A cross-sectional examination of caregiver mental health and childhood cancer survivors’ tobacco, alcohol, and marijuana use.

Fischer CM, Hamilton AS, Slaughter RI, Milam J.

Support Care Cancer. 2021 Jul;29(7):3649-3656. doi: 10.1007/s00520-020-05861-8. Epub 2020 Nov 12.

PMID: 33180201

26. A survey of Δ9-THC and relevant cannabinoids in products from the Italian market: A study by LC-MS/MS of food, beverages and feed.

Di Marco Pisciottano I, Guadagnuolo G, Soprano V, Esposito M, Gallo P.

Food Chem. 2021 Jun 1;346:128898. doi: 10.1016/j.foodchem.2020.128898. Epub 2020 Dec 25.

PMID: 33453579

27. Engaging in Risky and Impulsive Behaviors to Alleviate Distress Mediates Associations Between Intolerance of Uncertainty and Externalizing Psychopathology.

Sadeh N, Bredemeier K.

J Pers Disord. 2021 Jun;35(3):393-408. doi: 10.1521/pedi_2019_33_456. Epub 2019 Nov 4.

PMID: 31682196

28. Unknown population-level harms of cannabis and tobacco co-use: if you don’t measure it, you can’t manage it.

Hindocha C, McClure EA.

Addiction. 2021 Jul;116(7):1622-1630. doi: 10.1111/add.15290. Epub 2020 Nov 20.

PMID: 33047862

29. Racial/Ethnic Bullying Subtypes and Alcohol, Tobacco, and Marijuana Use Among US Adolescents.

Hong JS, Kim DH, Hunter SC, Cleeland LR, Lee CA, Lee JJ, Kim J.

J Racial Ethn Health Disparities. 2021 Jun 21. doi: 10.1007/s40615-021-01081-w. Online ahead of print.

PMID: 34152586

30. Marijuana and β-estradiol interactions on spatial learning and memory in young female rats: Lack of role of the G protein-coupled estrogen receptor (GPR30).

Chahkandi M, Komeili G, Sepehri G, Khaksari M, Amiresmaili S.

Life Sci. 2021 Jun 16;280:119723. doi: 10.1016/j.lfs.2021.119723. Online ahead of print.

PMID: 34146552

31. Addiction and the kynurenine pathway: A new dancing couple?

Morales-Puerto N, Giménez-Gómez P, Pérez-Hernández M, Abuin-Martínez C, Gil de Biedma-Elduayen L, Vidal R, Gutiérrez-López MD, O’Shea E, Colado MI.

Pharmacol Ther. 2021 Jul;223:107807. doi: 10.1016/j.pharmthera.2021.107807. Epub 2021 Jan 19.

PMID: 33476641 Review.

32. Gender Differences in Medical Cannabis Use: Symptoms Treated, Physician Support for Use, and Prescription Medication Discontinuation.

Bruce D, Grove TJ, Foster E, Shattell M.

J Womens Health (Larchmt). 2021 Jun;30(6):857-863. doi: 10.1089/jwh.2020.8437. Epub 2020 Oct 22.

PMID: 33090932

33. General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews.

Mohiuddin M, Blyth FM, Degenhardt L, Di Forti M, Eccleston C, Haroutounian S, Moore A, Rice ASC, Wallace M, Park R, Gilron I.

Pain. 2021 Jul 1;162(Suppl 1):S80-S96. doi: 10.1097/j.pain.0000000000002000.

PMID: 32941319

34. Alcohol-related cognitions: Implications for concurrent alcohol and marijuana use and concurrent alcohol and prescription stimulant misuse among young adults.

Litt DM, Lowery A, LoParco C, Lewis MA.

Addict Behav. 2021 Aug;119:106946. doi: 10.1016/j.addbeh.2021.106946. Epub 2021 Apr 6.

PMID: 33866222 Clinical Trial.

35. Adolescent Marijuana Use in the United States and Structural Breaks: An Age-Period-Cohort Analysis, 1991-2018.

Gu J, Guo X, Veenstra G, Zhu Y, Fu Q.

Am J Epidemiol. 2021 Jun 1;190(6):1056-1063. doi: 10.1093/aje/kwaa269.

PMID: 33324982

36. Risk factors for alcohol, marijuana, and cigarette polysubstance use during adolescence and young adulthood: A 7-year longitudinal study of youth at high risk for smoking escalation.

Crane NA, Langenecker SA, Mermelstein RJ.

Addict Behav. 2021 Aug;119:106944. doi: 10.1016/j.addbeh.2021.106944. Epub 2021 Apr 6.

PMID: 33872847

37. Apathy and anhedonia in adult and adolescent cannabis users and controls before and during the COVID-19 pandemic lockdown.

Skumlien M, Langley C, Lawn W, Voon V, Sahakian BJ.

Int J Neuropsychopharmacol. 2021 Jun 2:pyab033. doi: 10.1093/ijnp/pyab033. Online ahead of print.

PMID: 34077523

38. Oscillatory potentials abnormalities in regular cannabis users: Amacrine cells dysfunction as a marker of central dopaminergic modulation.

Polli L, Schwan R, Albuisson E, Malbos L, Angioi-Duprez K, Laprevote V, Schwitzer T.

Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jun 8;108:110083. doi: 10.1016/j.pnpbp.2020.110083. Epub 2020 Aug 27.

PMID: 32860840

39. Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013-2017 Traffic Safety Culture Index.

Benedetti MH, Li L, Neuroth LM, Humphries KD, Brooks-Russell A, Zhu M.

BMC Res Notes. 2021 Jun 3;14(1):226. doi: 10.1186/s13104-021-05643-3.

PMID: 34082823 Free PMC article.

40. Acceptance of Drug Use Mediates Future Hard Drug Use Among At-Risk Adolescent Marijuana, Tobacco, and Alcohol Users.

Cappelli C, Ames SL, Xie B, Pike JR, Stacy AW.

Prev Sci. 2021 Jul;22(5):545-554. doi: 10.1007/s11121-020-01165-9. Epub 2020 Sep 15.

PMID: 32929694

41. Marijuana use and sleep quality during pregnancy.

Murnan AW, Keim SA, Li R, Klebanoff MA.

J Matern Fetal Neonatal Med. 2021 Jun 8:1-8. doi: 10.1080/14767058.2021.1937987. Online ahead of print.

PMID: 34102934

42. Reaching nontreatment-seeking cannabis users: Testing an extended marijuana check-up intervention.

Stephens RS, Walker R, Fearer SA, Roffman RA.

J Subst Abuse Treat. 2021 Jun;125:108269. doi: 10.1016/j.jsat.2020.108269. Epub 2020 Dec 28.

PMID: 34016293

43. Maternal Substance Abuse and the Later Risk of Fractures in Offspring: L’abus maternel de substances et le risque ultérieur de fractures chez les enfants.

Auger N, Low N, Ayoub A, Lee GE, Luu TM.

Can J Psychiatry. 2021 Jun;66(6):551-559. doi: 10.1177/0706743720970826. Epub 2020 Nov 3.

PMID: 33140975

44. Predicting Substance Use from Religiosity/Spirituality in Individuals with Cystic Fibrosis.

Burgess BE, Mrug S, Bray LA, Leon KJ, Troxler RB.

J Relig Health. 2021 Jun;60(3):1818-1831. doi: 10.1007/s10943-020-01119-z. Epub 2021 Jan 3.

PMID: 33389481

45. Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic.

Boehnke KF, McAfee J, Ackerman JM, Kruger DJ.

Int J Drug Policy. 2021 Jun;92:103053. doi: 10.1016/j.drugpo.2020.103053. Epub 2020 Nov 24.

PMID: 33250438 Free PMC article.

46. Independent association of marijuana use and poor oral hygiene with HPV-negative but not HPV-positive head and neck squamous cell carcinomas.

Shewale JB, Pickard RKL, Xiao W, Jiang B, Gillison ML.

Cancer. 2021 Jun 15;127(12):2099-2110. doi: 10.1002/cncr.33440. Epub 2021 Feb 23.

PMID: 33620741

47. Differential Diagnosis of Sluggish Cognitive Tempo Symptoms in College Students.

Lovett BJ, Wood WLM, Lewandowski LJ.

J Atten Disord. 2021 Jul;25(9):1251-1259. doi: 10.1177/1087054719896856. Epub 2020 Jan 6.

PMID: 31904293

48. Drugs of Abuse and Heart Failure.

Grubb AF, Greene SJ, Fudim M, Dewald T, Mentz RJ.

J Card Fail. 2021 Jun 13:S1071-9164(21)00216-5. doi: 10.1016/j.cardfail.2021.05.023. Online ahead of print.

PMID: 34133967 Review.

49. Marijuana legalization and household spending on food and alcohol.

Lu T.

Health Econ. 2021 Jul;30(7):1684-1696. doi: 10.1002/hec.4266. Epub 2021 Apr 19.

PMID: 33876471

50. Integrative Medicine: Cannabis and Cannabis-Related Drugs.

Moss DA, Hawks MK, Snyder MJ, Crawford PF 3rd.

FP Essent. 2021 Jun;505:28-34.

PMID: 34128629

51. Efficacy of cannabinoids against glioblastoma multiforme: A systematic review.

Kyriakou I, Yarandi N, Polycarpou E.

Phytomedicine. 2021 Jul 15;88:153533. doi: 10.1016/j.phymed.2021.153533. Epub 2021 Mar 5.

PMID: 33812759 Review.

52. Quantification of Prenatal Marijuana Use: Evaluation of the Correlation between Self-Report, Serum, Urine and Umbilical Cord Assays among Women Delivering at Two Urban Colorado Hospitals.

Metz TD, McMillin GA, Silver RM, Allshouse AA, Heard K, Jensen TL, Wymore EM, Stickrath E, Conageski C, Kinney GL, Binswanger IA.

Addiction. 2021 Jun 17. doi: 10.1111/add.15606. Online ahead of print.

PMID: 34142398

53. Modeling and optimizing callus growth and development in Cannabis sativa using random forest and support vector machine in combination with a genetic algorithm.

Hesami M, Jones AMP.

Appl Microbiol Biotechnol. 2021 Jun 4. doi: 10.1007/s00253-021-11375-y. Online ahead of print.

PMID: 34086118

54. Tobacco and cannabis poly-substance and poly-product use trajectories across adolescence and young adulthood.

Lanza HI, Bello MS, Cho J, Barrington-Trimis JL, McConnell R, Braymiller JL, Krueger EA, Leventhal AM.

Prev Med. 2021 Jul;148:106545. doi: 10.1016/j.ypmed.2021.106545. Epub 2021 Apr 1.

PMID: 33812854

55. Growing pains: An overview of cannabis quality control and quality assurance in Canada.

Pusiak RJ, Cox C, Harris CS.

Int J Drug Policy. 2021 Jul;93:103111. doi: 10.1016/j.drugpo.2021.103111. Epub 2021 Jan 18.

PMID: 33478804 Review.

56. Toxicology of flavoring- and cannabis-containing e-liquids used in electronic delivery systems.

Stefaniak AB, LeBouf RF, Ranpara AC, Leonard SS.

Pharmacol Ther. 2021 Aug;224:107838. doi: 10.1016/j.pharmthera.2021.107838. Epub 2021 Mar 18.

PMID: 33746051 Review.

57. Alcohol, cigarette, e-cigarette and marijuana use among adolescents and young adults with chronic kidney disease in North America.

Molino AR, Jerry-Fluker J, Atkinson MA, Furth SL, Warady BA, Ng DK.

Ann Epidemiol. 2021 Jul;59:56-63. doi: 10.1016/j.annepidem.2021.04.001. Epub 2021 Apr 22.

PMID: 33894386

58. Determination of eighty-two pesticides and application to screening pesticides in cannabis growing facilities.

Craven CB, Birjandi AP, Simons B, Jiang P, Li XF.

J Environ Sci (China). 2021 Jun;104:11-16. doi: 10.1016/j.jes.2020.11.004. Epub 2020 Dec 10.

PMID: 33985714

59. Interventions to Prevent Drugged Driving: A Systematic Review.

Razaghizad A, Windle SB, Gore G, Benedetti A, Ells C, Grad R, Filion KB, Eisenberg MJ.

Am J Prev Med. 2021 Jun 4:S0749-3797(21)00223-3. doi: 10.1016/j.amepre.2021.03.012. Online ahead of print.

PMID: 34099354 Review.

60. A review of research-supported group treatments for drug use disorders.

López G, Orchowski LM, Reddy MK, Nargiso J, Johnson JE.

Subst Abuse Treat Prev Policy. 2021 Jun 21;16(1):51. doi: 10.1186/s13011-021-00371-0.

PMID: 34154619 Free PMC article. Review.

61. Toxicology of Psychoactive Substances.

Prisco L, Sarwal A, Ganau M, Rubulotta F.

Crit Care Clin. 2021 Jul;37(3):517-541. doi: 10.1016/j.ccc.2021.03.013.

PMID: 34053704 Review.

62. Marijuana improved motor impairments and changes in synaptic plasticity-related molecules in the striatum in 6-OHDA-treated rats.

Komeili G, Haghparast E, Sheibani V.

Behav Brain Res. 2021 Jul 23;410:113342. doi: 10.1016/j.bbr.2021.113342. Epub 2021 May 4.

PMID: 33961911

63. Alcohol, Marijuana and Other Illicit Drugs Use Throughout Adolescence: Co-occurring Courses and Preadolescent Risk-Factors.

Carbonneau R, Vitaro F, Brendgen M, Tremblay RE.

Child Psychiatry Hum Dev. 2021 Jun 10. doi: 10.1007/s10578-021-01202-w. Online ahead of print.

PMID: 34110528

64. Patterns of polyvictimization predict stimulant use, alcohol and marijuana problems in a large cohort of sexual minority and gender minority youth assigned male at birth.

Xavier Hall CD, Newcomb ME, Dyar C, Mustanski B.

Psychol Addict Behav. 2021 Jun 3. doi: 10.1037/adb0000751. Online ahead of print.

PMID: 34081488

65. Developmental Differences in Sexual Orientation and Gender Identity-Related Substance Use Disparities: Findings From Population-Based Data.

Fish JN, Bishop MD, Russell ST.

J Adolesc Health. 2021 Jun;68(6):1162-1169. doi: 10.1016/j.jadohealth.2020.10.023. Epub 2021 Jan 19.

PMID: 33478920

66. Potency testing of cannabinoids by liquid and supercritical fluid chromatography: Where we are, what we need.

Felletti S, De Luca C, Buratti A, Bozza D, Cerrato A, Capriotti AL, Laganà A, Cavazzini A, Catani M.

J Chromatogr A. 2021 Jun 1;1651:462304. doi: 10.1016/j.chroma.2021.462304. Online ahead of print.

PMID: 34118531 Review.

67. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies.

Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, Il Shin J, Kirkbride JB, Jones P, Kim JH, Kim JY, Carvalho AF, Seeman MV, Correll CU, Fusar-Poli P.

Mol Psychiatry. 2021 Jun 2. doi: 10.1038/s41380-021-01161-7. Online ahead of print.

PMID: 34079068 Review.

68. Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings.

Kesner AJ, Lovinger DM.

J Neurochem. 2021 Jun;157(5):1674-1696. doi: 10.1111/jnc.15369. Epub 2021 May 16.

PMID: 33891706 Review.

69. Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review.

McCartney D, Arkell TR, Irwin C, McGregor IS.

Neurosci Biobehav Rev. 2021 Jul;126:175-193. doi: 10.1016/j.neubiorev.2021.01.003. Epub 2021 Jan 23.

PMID: 33497784 Review.

70. The why behind the high: determinants of neurocognition during acute cannabis exposure.

Ramaekers JG, Mason NL, Kloft L, Theunissen EL.

Nat Rev Neurosci. 2021 Jul;22(7):439-454. doi: 10.1038/s41583-021-00466-4. Epub 2021 May 27.

PMID: 34045693 Review.

71. Cannabis and synaptic reprogramming of the developing brain.

Bara A, Ferland JN, Rompala G, Szutorisz H, Hurd YL.

Nat Rev Neurosci. 2021 Jul;22(7):423-438. doi: 10.1038/s41583-021-00465-5. Epub 2021 May 21.

PMID: 34021274 Review.

72. Self-reported and Documented Substance Use Among Adolescents in the Pediatric Hospital.

Masonbrink AR, Hunt JA, Bhandal A, Randell KA, Mermelstein S, Wells S, Miller MK.

Pediatrics. 2021 Jun;147(6):e2020031468. doi: 10.1542/peds.2020-031468. Epub 2021 May 3.

PMID: 33941583

73. A cluster randomized controlled trial evaluating the effectiveness of the school-based drug prevention program #Tamojunto2.0.

Sanchez ZM, Valente JY, Galvão PP, Gubert FA, Melo MHS, Caetano SC, Mari JJ, Cogo-Moreira H.

Addiction. 2021 Jun;116(6):1580-1592. doi: 10.1111/add.15358. Epub 2021 Jan 28.

PMID: 33245788

74. Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA.

Chiu V, Leung J, Hall W, Stjepanović D, Degenhardt L.

Neuropharmacology. 2021 Aug 1;193:108610. doi: 10.1016/j.neuropharm.2021.108610. Epub 2021 May 16.

PMID: 34010617 Review.

75. Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review.

Furgiuele A, Cosentino M, Ferrari M, Marino F.

J Neuroimmune Pharmacol. 2021 Jun;16(2):251-269. doi: 10.1007/s11481-021-09982-7. Epub 2021 Jan 25.

PMID: 33492630 Free PMC article. Review.

76. A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19.

Zolopa C, Hoj S, Bruneau J, Meeson JS, Minoyan N, Raynault MF, Makarenko I, Larney S.

Int J Drug Policy. 2021 Jun;92:103127. doi: 10.1016/j.drugpo.2021.103127. Epub 2021 Jan 20.

PMID: 33549464 Free PMC article. Review.

77. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination.

Robaina Cabrera CL, Keir-Rudman S, Horniman N, Clarkson N, Page C.

Pulm Pharmacol Ther. 2021 Jun 1;69:102047. doi: 10.1016/j.pupt.2021.102047. Online ahead of print.

PMID: 34082108

78. Cannabis and Its Different Strains.

Muro A, Cladellas R, Castellà J.

Exp Psychol. 2021 Jun 22:1-10. doi: 10.1027/1618-3169/a000510. Online ahead of print.

PMID: 34155905

79. Quantification of cannabinoids in human hair using a modified derivatization procedure and liquid chromatography-tandem mass spectrometry.

Al-Zahrani MA, Al-Asmari AI, Al-Zahrani FF, Torrance HJ, Watson DG.

Drug Test Anal. 2021 Jun;13(6):1095-1107. doi: 10.1002/dta.3005. Epub 2021 Feb 16.

PMID: 33491296

80. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC), and their Metabolites Following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.

Sholler DJ, Spindle TR, Cone EJ, Goffi E, Kuntz D, Mitchell JM, Winecker RE, Bigelow GE, Flegel RR, Vandrey R.

J Anal Toxicol. 2021 Jun 5:bkab059. doi: 10.1093/jat/bkab059. Online ahead of print.

PMID: 34089060

81. Converging public health crises: substance use during the coronavirus disease 2019 pandemic.

Striley CW, Hoeflich CC.

Curr Opin Psychiatry. 2021 Jul 1;34(4):325-331. doi: 10.1097/YCO.0000000000000722.

PMID: 34001699 Free PMC article. Review.

82. A co-twin-control analysis of adolescent and young adult drinking effects on learning and memory.

Malone SM, Wilson S, Bair JL, McGue M, Iacono WG.

Addiction. 2021 Jul;116(7):1689-1699. doi: 10.1111/add.15334. Epub 2021 Jan 28.

PMID: 33197098

83. The effect of daily aerobic cycling exercise on sleep quality during inpatient cannabis withdrawal: A randomised controlled trial.

McCartney D, Isik AD, Rooney K, Arnold JC, Bartlett DJ, Murnion B, Richards E, Arkell TR, Lintzeris N, McGregor IS.

J Sleep Res. 2021 Jun;30(3):e13211. doi: 10.1111/jsr.13211. Epub 2020 Oct 19.

PMID: 33078435

84. Binge Drinking, Tobacco, and Marijuana Use Among Young Adult Childhood Cancer Survivors: A Longitudinal Study.

Cappelli C, Miller KA, Ritt-Olson A, Pentz MA, Salahpour S, Milam JE.

J Pediatr Oncol Nurs. 2021 Jun 7:10434542211011036. doi: 10.1177/10434542211011036. Online ahead of print.

PMID: 34096807

85. Medical cannabis and driving.

Arkell TR, McCartney D, McGregor IS.

Aust J Gen Pract. 2021 Jun;50(6):357-362. doi: 10.31128/AJGP-02-21-5840.

PMID: 34059836

86. Polysubstance abuse among sexually abused in alcohol, drug, and gambling addiction treatment in Greenland: a cross sectional study.

Leth SV, Bjerrum ML, Niclasen BV.

Int J Circumpolar Health. 2021 Dec;80(1):1849909. doi: 10.1080/22423982.2020.1849909.

PMID: 33250010 Free PMC article.

87. A 17-Year-Old Girl with a Recent History of Marijuana Use Presented with Pneumomediastinum and Pneumopericardium and Tested Positive for SARS-CoV-2 Infection on Hospital Admission.

Khan HH, Witkowski A, Clark JA, Mata A.

Am J Case Rep. 2021 Jun 16;22:e931800. doi: 10.12659/AJCR.931800.

PMID: 34131098

88. Association of Cannabis Use During Adolescence With Neurodevelopment.

Albaugh MD, Ottino-Gonzalez J, Sidwell A, Lepage C, Juliano A, Owens MM, Chaarani B, Spechler P, Fontaine N, Rioux P, Lewis L, Jeon S, Evans A, D’Souza D, Radhakrishnan R, Banaschewski T, Bokde ALW, Quinlan EB, Conrod P, Desrivières S, Flor H, Grigis A, Gowland P, Heinz A, Ittermann B, Martinot JL, Paillère Martinot ML, Nees F, Papadopoulos Orfanos D, Paus T, Poustka L, Millenet S, Fröhner JH, Smolka MN, Walter H, Whelan R, Schumann G, Potter A, Garavan H; IMAGEN Consortium.

JAMA Psychiatry. 2021 Jun 16. doi: 10.1001/jamapsychiatry.2021.1258. Online ahead of print.

PMID: 34132750

89. Trends and Factors Related to Blunt Use in Middle and High School Students, 2010-2020.

Ebrahimi Kalan M, Jebai R, Bursac Z, Popova L, Gautam P, Li W, Alqahtani MM, Taskin T, Atwell LL, Richards J, Ward KD, Behaleh R, Ben Taleb Z.

Pediatrics. 2021 Jun 14:e2020028159. doi: 10.1542/peds.2020-028159. Online ahead of print.

PMID: 34127552

90. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid.

Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Kaabi JA, Ojha S.

Biomed Pharmacother. 2021 Aug;140:111639. doi: 10.1016/j.biopha.2021.111639. Epub 2021 Jun 3.

PMID: 34091179 Review.

91. Kinetics of CBD, Δ9-THC Degradation and Cannabinol Formation in Cannabis Resin at Various Temperature and pH Conditions.

Jaidee W, Siridechakorn I, Nessopa S, Wisuitiprot V, Chaiwangrach N, Ingkaninan K, Waranuch N.

Cannabis Cannabinoid Res. 2021 Jun 4. doi: 10.1089/can.2021.0004. Online ahead of print.

PMID: 34096805

92. The effect of cannabidiol on canine neoplastic cell proliferation and mitogen-activated protein kinase activation during autophagy and apoptosis.

Henry JG, Shoemaker G, Prieto JM, Hannon MB, Wakshlag JJ.

Vet Comp Oncol. 2021 Jun;19(2):253-265. doi: 10.1111/vco.12669. Epub 2021 Jan 14.

PMID: 33247539

93. Cannabis use disorder, anger, and violence in Iraq/Afghanistan-era veterans.

Dillon KH, Van Voorhees EE, Elbogen EB, Beckham JC; VA Mid-Atlantic MIRECC Workgroup, Calhoun PS.

J Psychiatr Res. 2021 Jun;138:375-379. doi: 10.1016/j.jpsychires.2021.04.018. Epub 2021 Apr 22.

PMID: 33933928

94. Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic.

Rapin L, Gamaoun R, El Hage C, Arboleda MF, Prosk E.

J Cannabis Res. 2021 Jun 23;3(1):19. doi: 10.1186/s42238-021-00078-w.

PMID: 34162446

95. Delivering therapeutic cannabinoids via skin: Current state and future perspectives.

Tijani AO, Thakur D, Mishra D, Frempong D, Chukwunyere UI, Puri A.

J Control Release. 2021 Jun 10;334:427-451. doi: 10.1016/j.jconrel.2021.05.005. Epub 2021 May 6.

PMID: 33964365 Review.

96. Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews.

Moore RA, Fisher E, Finn DP, Finnerup NB, Gilron I, Haroutounian S, Krane E, Rice ASC, Rowbotham M, Wallace M, Eccleston C.

Pain. 2021 Jul 1;162(Suppl 1):S67-S79. doi: 10.1097/j.pain.0000000000001941.

PMID: 32804833

97. A Comprehensive Review of Cannabis Potency in the United States in the Last Decade.

ElSohly MA, Chandra S, Radwan M, Majumdar CG, Church JC.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Jun;6(6):603-606. doi: 10.1016/j.bpsc.2020.12.016. Epub 2021 Jan 26.

PMID: 33508497 Review.

98. Evaluation of the trnK-matK-trnK, ycf3, and accD-psal chloroplast regions to differentiate crop type and biogeographical origin of Cannabis sativa.

Cheng YC, Houston R.

Int J Legal Med. 2021 Jul;135(4):1235-1244. doi: 10.1007/s00414-021-02518-x. Epub 2021 Feb 18.

PMID: 33604694

99. Cannabis use frequency, route of administration, and co-use with alcohol among older adults in Washington state.

Subbaraman MS, Kerr WC.

J Cannabis Res. 2021 Jun 3;3(1):17. doi: 10.1186/s42238-021-00071-3.

PMID: 34082833 Free PMC article.

100. Incarceration among adults living with psychosis in Indigenous populations in Cape York and the Torres Strait.

Charlson F, Gynther B, Obrecht K, Heffernan E, David M, Young JT, Hunter E.

Aust N Z J Psychiatry. 2021 Jul;55(7):678-686. doi: 10.1177/0004867420985247. Epub 2021 Jan 21.

PMID: 33478250

101. Heterogeneities in administration methods among cannabis users by use purpose and state legalization status: findings from a nationally representative survey in the United States, 2020.

Shi Y.

Addiction. 2021 Jul;116(7):1782-1793. doi: 10.1111/add.15342. Epub 2021 Jan 3.

PMID: 33217090

102. Cannabis Use During the Pre-Conception Period and Pregnancy After Legalization.

Bayrampour H, Asim A.

J Obstet Gynaecol Can. 2021 Jun;43(6):740-745. doi: 10.1016/j.jogc.2021.02.119. Epub 2021 Mar 5.

PMID: 33677139

103. Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases.

Rodríguez Mesa XM, Moreno Vergara AF, Contreras Bolaños LA, Guevara Moriones N, Mejía Piñeros AL, Santander González SP.

Cannabis Cannabinoid Res. 2021 Jun;6(3):196-210. doi: 10.1089/can.2020.0183. Epub 2021 May 24.

PMID: 34030476

104. Building a hospital-based addiction medicine consultation service in Vancouver, Canada: the path taken and lessons learned.

Braithwaite V, Ti L, Fairbairn N, Ahamad K, McLean M, Harrison S, Wood E, Nolan S.

Addiction. 2021 Jul;116(7):1892-1900. doi: 10.1111/add.15383. Epub 2021 Jan 27.

PMID: 33339073

105. Cannabis Abuse and Perioperative Complications Following Inpatient Spine Surgery in the United States.

Chiu RG, Patel S, Siddiqui N, Nunna RS, Mehta AI.

Spine (Phila Pa 1976). 2021 Jun 1;46(11):734-743. doi: 10.1097/BRS.0000000000004035.

PMID: 33769411

106. Differential diagnosis of the association of gastrointestinal symptoms and ST segment elevation, in the absence of chest pain.

Jolobe OMP.

Am J Emerg Med. 2021 Jun 4;49:137-141. doi: 10.1016/j.ajem.2021.05.067. Online ahead of print.

PMID: 34111833 Review.

107. Substance use and deaths by suicide: A latent class analysis of the National Violent Death Reporting System.

Culbreth R, Swahn MH, Osborne M, Brandenberger K, Kota K.

Prev Med. 2021 Jun 10:106682. doi: 10.1016/j.ypmed.2021.106682. Online ahead of print.

PMID: 34119594

108. Associations of Suicidality Trends With Cannabis Use as a Function of Sex and Depression Status.

Han B, Compton WM, Einstein EB, Volkow ND.

JAMA Netw Open. 2021 Jun 1;4(6):e2113025. doi: 10.1001/jamanetworkopen.2021.13025.

PMID: 34156452

109. Oxytocin signaling in the treatment of drug addiction: Therapeutic opportunities and challenges.

Che X, Cai J, Liu Y, Xu T, Yang J, Wu C.

Pharmacol Ther. 2021 Jul;223:107820. doi: 10.1016/j.pharmthera.2021.107820. Epub 2021 Feb 15.

PMID: 33600854 Review.

110. Pediatric cannabis intoxication trends in the pre and post-legalization era.

Cohen N, Galvis Blanco L, Davis A, Kahane A, Mathew M, Schuh S, Kestenbom I, Test G, Pasternak Y, Verstegen RHJ, Jung B, Maguire B, Rached d’Astous S, Rumantir M, Finkelstein Y.

Clin Toxicol (Phila). 2021 Jun 17:1-6. doi: 10.1080/15563650.2021.1939881. Online ahead of print.

PMID: 34137352

111. Clinical symptoms and personality traits predict subpopulations of treatment-seeking substance users.

Martínez-Loredo V, Macipe V, Errasti Pérez JM, Al-Halabí S.

J Subst Abuse Treat. 2021 Jun;125:108314. doi: 10.1016/j.jsat.2021.108314. Epub 2021 Jan 30.

PMID: 34016301

112. Cannabinoids: Emerging developments in neuropsychopharmacology and biological psychiatry.

Oleson EB, Khokhar JY.

Prog Neuropsychopharmacol Biol Psychiatry. 2021 Aug 30;110:110305. doi: 10.1016/j.pnpbp.2021.110305. Epub 2021 Mar 16.

PMID: 33737216

113. Predictors of cannabis and tobacco co-use in youth: exploring the mediating role of age at first use in the population assessment of tobacco health (PATH) study.

Smith CL, Cooper BR, Miguel A, Hill L, Roll J, McPherson S.

J Cannabis Res. 2021 Jun 1;3(1):16. doi: 10.1186/s42238-021-00072-2.

PMID: 34074338 Free PMC article.

114. A Mobile Intervention to Promote Low-Risk Drinking Habits in Young Adults: Protocol for a Randomized Controlled Trial.

Boumparis N, Schulte MH, Kleiboer A, Huizink A, Riper H.

JMIR Res Protoc. 2021 Jun 7;10(6):e29750. doi: 10.2196/29750.

PMID: 34033583

115. Trends and correlates of cocaine use among adults in the United States, 2006-2019.

Mustaquim D, Jones CM, Compton WM.

Addict Behav. 2021 Sep;120:106950. doi: 10.1016/j.addbeh.2021.106950. Epub 2021 Apr 20.

PMID: 33940336

116. Precursors of self-reported subclinical hypomania in adolescence: A longitudinal general population study.

Nielsen LG, Køster Rimvall M, Van Os J, Verhulst F, Rask CU, Skovgaard AM, Olsen EM, Jeppesen P.

PLoS One. 2021 Jun 18;16(6):e0253507. doi: 10.1371/journal.pone.0253507. eCollection 2021.

PMID: 34143836

117. Prevalence of cannabis use among individuals with a history of cancer in the United States.

Cousins MM, Jannausch ML, Coughlin LN, Jagsi R, Ilgen MA.

Cancer. 2021 Jun 3. doi: 10.1002/cncr.33646. Online ahead of print.

PMID: 34081772

118. Medicinal cannabis and driving: the intersection of health and road safety policy.

Perkins D, Brophy H, McGregor IS, O’Brien P, Quilter J, McNamara L, Sarris J, Stevenson M, Gleeson P, Sinclair J, Dietze P.

Int J Drug Policy. 2021 Jun 6;97:103307. doi: 10.1016/j.drugpo.2021.103307. Online ahead of print.

PMID: 34107448

119. Association between chronic psychoactive substances use and systemic inflammation: A systematic review and meta-analysis.

Doggui R, Elsawy W, Conti AA, Baldacchino A.

Neurosci Biobehav Rev. 2021 Jun;125:208-220. doi: 10.1016/j.neubiorev.2021.02.031. Epub 2021 Feb 24.

PMID: 33639179 Review.

120. The perceived effects of cannabis products in the management of seizures in CDKL5 Deficiency Disorder.

Dale T, Downs J, Wong K, Leonard H.

Epilepsy Behav. 2021 Jun 17:108152. doi: 10.1016/j.yebeh.2021.108152. Online ahead of print.

PMID: 34148781

121. Co-use measurement is also required in treatment interventions.

Walsh H, Duaso MJ.

Addiction. 2021 Jul;116(7):1633-1634. doi: 10.1111/add.15397. Epub 2021 Jan 18.

PMID: 33458914 No abstract available.

122. Medicinal cannabis in Thailand: 1-year experience after legalization.

Zinboonyahgoon N, Srisuma S, Limsawart W, Rice ASC, Suthisisang C.

Pain. 2021 Jul 1;162(Suppl 1):S105-S109. doi: 10.1097/j.pain.0000000000001936.

PMID: 33009244 No abstract available.

123. A High Note: Drug Misuse in Popular Rap Music.

Stickle B.

Subst Use Misuse. 2021 Jun 13:1-9. doi: 10.1080/10826084.2021.1936046. Online ahead of print.

PMID: 34121603

124. Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials.

McKee KA, Hmidan A, Crocker CE, Lam RW, Meyer JH, Crockford D, Trépanier A, Aitchison KJ, Tibbo PG.

J Psychiatr Res. 2021 Jun 1;140:267-281. doi: 10.1016/j.jpsychires.2021.05.044. Online ahead of print.

PMID: 34119912 Review.

125. Prevalence and Correlates of Driving Under the Influence of Cannabis in the U.S.

Salas-Wright CP, Cano M, Hai AH, Oh S, Vaughn MG.

Am J Prev Med. 2021 Jun;60(6):e251-e260. doi: 10.1016/j.amepre.2021.01.021. Epub 2021 Mar 13.

PMID: 33726992

126. A mixed-methods study to inform the clarity and accuracy of cannabis-use and cannabis-tobacco co-use survey measures.

Watkins SL, Karliner-Li P, Lee YO, Koester KA, Ling PM.

Drug Alcohol Depend. 2021 Jul 1;224:108697. doi: 10.1016/j.drugalcdep.2021.108697. Epub 2021 Apr 21.

PMID: 33930639

127. Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies.

Finn DP, Haroutounian S, Hohmann AG, Krane E, Soliman N, Rice ASC.

Pain. 2021 Jul 1;162(Suppl 1):S5-S25. doi: 10.1097/j.pain.0000000000002268.

PMID: 33729211

128. Adverse Reactions to Illicit Drugs (Marijuana, Opioids, Cocaine) and Alcohol.

Decuyper II, Armentia A, Martín-Armentia B, Almuzara AC, Ebo DG, Brucker HA.

J Allergy Clin Immunol Pract. 2021 Jun 19:S2213-2198(21)00567-5. doi: 10.1016/j.jaip.2021.04.061. Online ahead of print.

PMID: 33965592

129. Risk and protective factors for cannabis, cocaine, and opioid use disorders: An umbrella review of meta-analyses of observational studies.

Solmi M, Dragioti E, Croatto G, Radua J, Borgwardt S, Carvalho AF, Demurtas J, Mosina A, Kurotschka PK, Shin JI, Fusar-Poli P.

Neurosci Biobehav Rev. 2021 Jul;126:243-251. doi: 10.1016/j.neubiorev.2021.03.014. Epub 2021 Mar 15.

PMID: 33737104 Review.

130. Acute Δ9-tetrahydrocannabinol prompts rapid changes in cannabinoid CB1 receptor immunolabeling and subcellular structure in CA1 hippocampus of young adult male mice.

Bonilla-Del Río I, Puente N, Mimenza A, Ramos A, Serrano M, Lekunberri L, Gerrikagoitia I, Christie BR, Nahirney PC, Grandes P.

J Comp Neurol. 2021 Jun;529(9):2332-2346. doi: 10.1002/cne.25098. Epub 2021 Jan 5.

PMID: 33368252

131. Nicotine and cannabis vaping among adolescents in treatment for substance use disorders.

Young-Wolff KC, Adams SR, Sterling SA, Tan ASL, Salloum RG, Torre K, Carter-Harris L, Prochaska JJ.

J Subst Abuse Treat. 2021 Jun;125:108304. doi: 10.1016/j.jsat.2021.108304. Epub 2021 Jan 27.

PMID: 34016296

132. Sex differences in the acute pharmacological and subjective effects of smoked cannabis combined with alcohol in young adults.

Wright M, Wickens CM, Di Ciano P, Sproule B, Fares A, Matheson J, Mann RE, Rehm J, Shuper PA, George TP, Huestis MA, Stoduto G, Le Foll B, Brands B.

Psychol Addict Behav. 2021 Jun 3. doi: 10.1037/adb0000749. Online ahead of print.

PMID: 34081489

133. Role of sex on the relationship between sexual minority status and past 30-day marijuana use among high school students (YRBS, 2015-2019).

Mantey DS, Andrew Yockey R, Barroso CS.

Addict Behav. 2021 Jul;118:106905. doi: 10.1016/j.addbeh.2021.106905. Epub 2021 Mar 10.

PMID: 33752162

134. Association between marijuana use and nonmedical prescription opioid use in the United States: are we shifting from one epidemic to another?

Arora P, Johnson A, Jayasekare R, Desai K.

J Public Health Policy. 2021 Jun;42(2):310-321. doi: 10.1057/s41271-021-00282-1. Epub 2021 Apr 20.

PMID: 33879832

135. Educating Residents About Cannabis: Results of a Needs Assessment.

Soroka C, Gardner DM, Hazelton L.

Acad Psychiatry. 2021 Jun;45(3):329-333. doi: 10.1007/s40596-021-01423-0. Epub 2021 Mar 3.

PMID: 33660236

136. Dual trajectories of cannabis and alcohol use among young adults in a state with legal nonmedical cannabis.

Guttmannova K, Fleming CB, Rhew IC, Alisa Abdallah D, Patrick ME, Duckworth JC, Lee CM.

Alcohol Clin Exp Res. 2021 Jun 5. doi: 10.1111/acer.14629. Online ahead of print.

PMID: 34089527

137. Cannabis and mental health: Prevalence of use and modes of cannabis administration by mental health status.

Rup J, Freeman TP, Perlman C, Hammond D.

Addict Behav. 2021 Oct;121:106991. doi: 10.1016/j.addbeh.2021.106991. Epub 2021 May 19.

PMID: 34087766

138. Assessing cannabis and tobacco co-use: the pros and cons of additional data collection.

McRobbie H, Boland VC, Courtney RJ.

Addiction. 2021 Jul;116(7):1631-1633. doi: 10.1111/add.15373. Epub 2021 Jan 8.

PMID: 33417256 No abstract available.

139. Cannabinoid-induced changes in the immune system: The role of microRNAs.

Bhatt HK, Song D, Musgrave G, Rao PSS.

Int Immunopharmacol. 2021 Jun 6;98:107832. doi: 10.1016/j.intimp.2021.107832. Online ahead of print.

PMID: 34107381 Review.

140. Origin and evolution of the cannabinoid oxidocyclase gene family.

van Velzen R, Schranz ME.

Genome Biol Evol. 2021 Jun 8:evab130. doi: 10.1093/gbe/evab130. Online ahead of print.

PMID: 34100927

141. Substance use behaviors in the daily lives of U.S. college students reporting recent use: The varying roles of romantic relationships.

Blumenstock SM, Papp LM.

Soc Sci Med. 2021 Jun;279:114021. doi: 10.1016/j.socscimed.2021.114021. Epub 2021 May 10.

PMID: 34004570

142. Investigating interventions that lead to the highest treatment retention for emerging adults with substance use disorder: A systematic review.

Dalton K, Bishop L, Darcy S.

Addict Behav. 2021 Jun 3;122:107005. doi: 10.1016/j.addbeh.2021.107005. Online ahead of print.

PMID: 34119856 Review.

143. Profiles of young women’s alcohol and cannabis use linked to risk for sexually transmitted infection highlight the importance of multi-level targeted interventions: Findings from the Pittsburgh girls study.

Chung T, Hipwell AE, Stepp SD, Miller E, Sartor CE.

Subst Abus. 2021 Jun 18:1-9. doi: 10.1080/08897077.2021.1931634. Online ahead of print.

PMID: 34143947

144. “If I knew I could get that every hour instead of alcohol, I would take the cannabis”: need and feasibility of cannabis substitution implementation in Canadian managed alcohol programs.

Pauly B, Brown M, Chow C, Wettlaufer A; East Side Illicit Drinkers Group for Education (EIDGE), Graham B, Urbanoski K, Callaghan R, Rose C, Jordan M, Stockwell T, Thomas G, Sutherland C.

Harm Reduct J. 2021 Jun 23;18(1):65. doi: 10.1186/s12954-021-00512-5.

PMID: 34162375

145. A reinforcer pathology approach to cannabis misuse: Evaluation of independent and interactive roles of cannabis demand and delay discounting in a sample of community adults.

McIntyre-Wood C, Minhas M, Balodis I, Murphy JG, MacKillop J.

Exp Clin Psychopharmacol. 2021 Jun 7. doi: 10.1037/pha0000485. Online ahead of print.

PMID: 34096758

146. Scandalous decisions: explaining shifts in UK medicinal cannabis policy.

Monaghan M, Wincup E, Hamilton I.

Addiction. 2021 Jul;116(7):1925-1933. doi: 10.1111/add.15350. Epub 2021 Jan 6.

PMID: 33404120

147. The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization.

Coronado-Álvarez A, Romero-Cordero K, Macías-Triana L, Tatum-Kuri A, Vera-Barrón A, Budde H, Machado S, Yamamoto T, Imperatori C, Murillo-Rodríguez E.

Prog Neuropsychopharmacol Biol Psychiatry. 2021 Aug 30;110:110301. doi: 10.1016/j.pnpbp.2021.110301. Epub 2021 Mar 17.

PMID: 33741446 Review.

148. The embodiment of wastewater data for the estimation of illicit drug consumption in Spain.

Bijlsma L, Picó Y, Andreu V, Celma A, Estévez-Danta A, González-Mariño I, Hernández F, López de Alda M, López-García E, Marcé RM, Miró M, Montes R, Pérez de San Román-Landa U, Pitarch E, Pocurull E, Postigo C, Prieto A, Rico A, Rodil R, Valcárcel Y, Ventura M, Quintana JB.

Sci Total Environ. 2021 Jun 10;772:144794. doi: 10.1016/j.scitotenv.2020.144794. Epub 2021 Jan 26.

PMID: 33770873

149. Effect of COVID-19 Pandemic on Cannabis Use in Cancer Patients.

Donovan KA, Portman DG.

Am J Hosp Palliat Care. 2021 Jul;38(7):850-853. doi: 10.1177/1049909121999784. Epub 2021 Mar 4.

PMID: 33657874

150. Archaeobotanical evidence of the use of medicinal cannabis in a secular context unearthed from south China.

Bai Y, Jiang M, Xie T, Jiang C, Gu M, Zhou X, Yan X, Yuan Y, Huang L.

J Ethnopharmacol. 2021 Jul 15;275:114114. doi: 10.1016/j.jep.2021.114114. Epub 2021 Apr 20.

PMID: 33848611

151. Cannabis and its cannabinoids analysis by gas chromatography-mass spectrometry with Cold EI.

Amirav A, Neumark B, Margolin Eren KJ, Fialkov AB, Tal N.

J Mass Spectrom. 2021 Jun;56(6):e4726. doi: 10.1002/jms.4726.

PMID: 33955098

152. All in the family: parental substance misuse, harsh parenting, and youth substance misuse among juvenile justice-involved youth.

Bosk EA, Anthony WL, Folk JB, Williams-Butler A.

Addict Behav. 2021 Aug;119:106888. doi: 10.1016/j.addbeh.2021.106888. Epub 2021 Mar 4.

PMID: 33798920

153. Tobacco Screening and Use in Hospitalized Adolescents at a Children’s Hospital.

Alexander A, Honan R, Molina A, Rahman AKMF, Walley SC.

Hosp Pediatr. 2021 Jun;11(6):605-612. doi: 10.1542/hpeds.2020-002311. Epub 2021 May 20.

PMID: 34016650

154. Cannabidiol in low back pain: scientific rationale for clinical trials in low back pain.

Xantus G, Zavori L, Matheson C, Gyarmathy VA, Fazekas LM, Kanizsai P.

Expert Rev Clin Pharmacol. 2021 Jun;14(6):671-675. doi: 10.1080/17512433.2021.1917379. Epub 2021 Apr 28.

PMID: 33861675 Review.

155. Scopolamine fatal outcome in an inmate after buscopan® smoking.

Strano-Rossi S, Mestria S, Bolino G, Polacco M, Grassi S, Oliva A.

Int J Legal Med. 2021 Jul;135(4):1455-1460. doi: 10.1007/s00414-021-02583-2. Epub 2021 Apr 23.

PMID: 33890166 Free PMC article.

156. Use of health care services by people with substance use disorders in Belgium: a register-based cohort study.

Van Baelen L, Plettinckx E, Antoine J, De Ridder K, Devleesschauwer B, Gremeaux L.

Arch Public Health. 2021 Jun 23;79(1):112. doi: 10.1186/s13690-021-00620-5.

PMID: 34162427

157. A synthesis of the literature to inform vaping cessation interventions for young adults.

Berg CJ, Krishnan N, Graham AL, Abroms LC.

Addict Behav. 2021 Aug;119:106898. doi: 10.1016/j.addbeh.2021.106898. Epub 2021 Mar 8.

PMID: 33894483

158. Changes in cannabis, tobacco, and alcohol use among sexually active female adolescents and young adults over a twelve-year period ending in 2019.

Shyhalla K, Smith DM, Diaz A, Nucci-Sack A, Guillot M, Hollman D, Goniewicz ML, O’Connor RJ, Shankar V, Burk RD, Schlecht NF.

Addict Behav. 2021 Oct;121:106994. doi: 10.1016/j.addbeh.2021.106994. Epub 2021 May 24.

PMID: 34087767 Free PMC article.

159. Citalopram and Cannabidiol: In Vitro and In Vivo Evidence of Pharmacokinetic Interactions Relevant to the Treatment of Anxiety Disorders in Young People.

Anderson LL, Doohan PT, Oldfield L, Kevin RC, Arnold JC, Berger M, Amminger GP, McGregor IS.

J Clin Psychopharmacol. 2021 Jun 11. doi: 10.1097/JCP.0000000000001427. Online ahead of print.

PMID: 34121064

160. Cannabidiol-Driven Alterations to Inflammatory Protein Landscape of Lipopolysaccharide-Activated Macrophages In Vitro May Be Mediated by Autophagy and Oxidative Stress.

Yeisley DJ, Arabiyat AS, Hahn MS.

Cannabis Cannabinoid Res. 2021 Jun;6(3):253-263. doi: 10.1089/can.2020.0109. Epub 2021 Mar 25.

PMID: 33998893

161. Distress tolerance and subsequent substance use throughout high school.

Kechter A, Barrington-Trimis JL, Cho J, Davis JP, Huh J, Black DS, Leventhal AM.

Addict Behav. 2021 Sep;120:106983. doi: 10.1016/j.addbeh.2021.106983. Epub 2021 May 8.

PMID: 34010760

162. The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies.

Henshaw FR, Dewsbury LS, Lim CK, Steiner GZ.

Cannabis Cannabinoid Res. 2021 Jun;6(3):177-195. doi: 10.1089/can.2020.0105. Epub 2021 Apr 28.

PMID: 33998900

163. A method and its application to determine the amount of cannabinoids in sewage sludge and biosolids.

Pandopulos AJ, Simpson BS, Bade R, O’Brien JW, Yadav MK, White JM, Gerber C.

Environ Sci Pollut Res Int. 2021 Jun 18. doi: 10.1007/s11356-021-14921-3. Online ahead of print.

PMID: 34143389

164. Effect of COVID-19 disruptions on young adults’ affect and substance use in daily life.

Papp LM, Kouros CD.

Psychol Addict Behav. 2021 Jun;35(4):391-401. doi: 10.1037/adb0000748. Epub 2021 May 20.

PMID: 34014686

165. Cannabis Use, Pulmonary Function, and Lung Cancer Susceptibility: A Mendelian Randomization Study.

Baumeister SE, Baurecht H, Nolde M, Alayash Z, Gläser S, Johansson M, Amos CI; International Lung Cancer Consortium, Johnson EC, Hung RJ.

J Thorac Oncol. 2021 Jul;16(7):1127-1135. doi: 10.1016/j.jtho.2021.03.025. Epub 2021 Apr 20.

PMID: 33852959

166. Gabapentin attenuates somatic signs of precipitated THC withdrawal in mice.

Eckard ML, Kinsey SG.

Neuropharmacology. 2021 Jun 1;190:108554. doi: 10.1016/j.neuropharm.2021.108554. Epub 2021 Apr 15.

PMID: 33845073

167. The Cannabinoids Tetrahydrocannabinol, Cannabinol, Cannabidiol, Tetrahydrocannabivarin, and 11-nor-9-carboxy-∆9-THC in Hair.

Hill VA, Schaffer MI, Paulsen RB, Stowe GN.

J Anal Toxicol. 2021 Jun 21:bkab068. doi: 10.1093/jat/bkab068. Online ahead of print.

PMID: 34153110

168. Cultural conformity and cannabis care in the wake of intractable pediatric epilepsy.

Sobo EJ.

Anthropol Med. 2021 Jun 2:1-18. doi: 10.1080/13648470.2021.1893583. Online ahead of print.

PMID: 34075822

169. Diacylglycerol Lipase-β Knockout Mice Display a Sex-Dependent Attenuation of Traumatic Brain Injury-Induced Mortality with No Impact on Memory or Other Functional Consequences.

O’Brien LD, Smith TL, Donvito G, Cravatt BF, Newton J, Spiegel S, Reeves TM, Phillips LL, Lichtman AH.

Cannabis Cannabinoid Res. 2021 Jun 17. doi: 10.1089/can.2020.0175. Online ahead of print.

PMID: 34142866

170. Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics.

Schlag AK, O’Sullivan SE, Zafar RR, Nutt DJ.

Neuropharmacology. 2021 Jun 15;191:108586. doi: 10.1016/j.neuropharm.2021.108586. Epub 2021 May 1.

PMID: 33940011 Review.

171. Improved Maternal and Infant Outcomes with Serial, Self-Reported Early Prenatal Substance Use Screening.

Boden SL, Jones CW, Cabacungan ET.

Matern Child Health J. 2021 Jul;25(7):1118-1125. doi: 10.1007/s10995-021-03127-1. Epub 2021 Apr 27.

PMID: 33904025

172. Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine.

Lehmann K, Kuhn S, Baschirotto C, Jacobsen B, Walcher S, Görne H, Backmund M, Scherbaum N, Reimer J, Verthein U.

J Subst Abuse Treat. 2021 Aug;127:108350. doi: 10.1016/j.jsat.2021.108350. Epub 2021 Mar 4.

PMID: 34134867

173. Cannabinoids and myocardial ischemia: Novel insights, updated mechanisms, and implications for myocardial infarction.

El-Dahan KS, Machtoub D, Massoud G, Nasser SA, Hamam B, Kobeissy F, Zouein FA, Eid AH.

Curr Med Chem. 2021 Jun 8. doi: 10.2174/0929867328666210608144818. Online ahead of print.

PMID: 34102966

174. Feasibility of a Web-Accessible Game-Based Intervention Aimed at Improving Help Seeking and Coping Among Sexual and Gender Minority Youth: Results From a Randomized Controlled Trial.

Egan JE, Corey SL, Henderson ER, Abebe KZ, Louth-Marquez W, Espelage D, Hunter SC, DeLucas M, Miller E, Morrill BA, Hieftje K, Sang JM, Friedman MS, Coulter RWS.

J Adolesc Health. 2021 Jun 15:S1054-139X(21)00159-2. doi: 10.1016/j.jadohealth.2021.03.027. Online ahead of print.

PMID: 34140199

175. Correlates of driving after cannabis use in high school students.

Cantor N, Kingsbury M, Hamilton HA, Wild TC, Owusu-Bempah A, Colman I.

Prev Med. 2021 Jun 1;150:106667. doi: 10.1016/j.ypmed.2021.106667. Online ahead of print.

PMID: 34081937

176. Development of individuals’ own and perceptions of peers’ substance use from early adolescence to adulthood.

Lansford JE, Goulter N, Godwin J, Crowley M, McMahon RJ, Bates JE, Pettit GS, Greenberg M, Lochman JE, Dodge KA.

Addict Behav. 2021 Sep;120:106958. doi: 10.1016/j.addbeh.2021.106958. Epub 2021 Apr 20.

PMID: 33940335

177. Psychosocial predictors of substance use in adolescents and young adults: Longitudinal risk and protective factors.

Brumback T, Thompson W, Cummins K, Brown S, Tapert S.

Addict Behav. 2021 Oct;121:106985. doi: 10.1016/j.addbeh.2021.106985. Epub 2021 May 16.

PMID: 34087768

178. Cannabis alters epigenetic integrity and endocannabinoid signalling in the human follicular niche.

Fuchs Weizman N, Wyse BA, Szaraz P, Defer M, Jahangiri S, Librach CL.

Hum Reprod. 2021 Jun 18;36(7):1922-1931. doi: 10.1093/humrep/deab104.

PMID: 33954787 Free PMC article.

179. Gastroparesis with Cannabis Use: A Retrospective Study from the Nationwide Inpatient Sample.

Dahiya DS, Kichloo A, Shaka H, Singh J, Edigin E, Solanki D, Eseaton PO, Wani F.

Postgrad Med. 2021 Jun 15:1-7. doi: 10.1080/00325481.2021.1940219. Online ahead of print.

PMID: 34096455

180. Sexual excitation and sex-linked substance use predict overall cannabis use in mostly heterosexual and bisexual women.

Lorenz TK.

Am J Drug Alcohol Abuse. 2021 Jun 11:1-11. doi: 10.1080/00952990.2021.1922429. Online ahead of print.

PMID: 34114916

181. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management.

Haroutounian S, Arendt-Nielsen L, Belton J, Blyth FM, Degenhardt L, Di Forti M, Eccleston C, Finn DP, Finnerup NB, Fisher E, Fogarty AE, Gilron I, Hohmann AG, Kalso E, Krane E, Mohiuddin M, Moore RA, Rowbotham M, Soliman N, Wallace M, Zinboonyahgoon N, Rice ASC.

Pain. 2021 Jul 1;162(Suppl 1):S117-S124. doi: 10.1097/j.pain.0000000000002266.

PMID: 34138827

182. Modulatory Potential of Cannabidiol on the Opioid-Induced Inflammatory Response.

Johnson CT, Bradshaw HB.

Cannabis Cannabinoid Res. 2021 Jun;6(3):211-220. doi: 10.1089/can.2020.0181.

PMID: 34115948

183. Sleep-wake cycle disturbances and NeuN-altered expression in adult rats after cannabidiol treatments during adolescence.

Murillo-Rodríguez E, Millán-Aldaco D, Cicconcelli D, Giorgetti V, Arankowsky-Sandoval G, Alcaraz-Silva J, Imperatori C, Machado S, Budde H, Torterolo P.

Psychopharmacology (Berl). 2021 Jun;238(6):1437-1447. doi: 10.1007/s00213-021-05769-z. Epub 2021 Feb 26.

PMID: 33635384

184. Chronic cannabidiol (CBD) administration induces anticonvulsant and antiepileptogenic effects in a genetic model of epilepsy.

Lazarini-Lopes W, Do Val-da Silva RA, da Silva-Júnior RMP, Silva-Cardoso GK, Leite-Panissi CRA, Leite JP, Garcia-Cairasco N.

Epilepsy Behav. 2021 Jun;119:107962. doi: 10.1016/j.yebeh.2021.107962. Epub 2021 Apr 20.

PMID: 33887676

185. Redefining recovery: Accounts of treatment experiences of dependent cannabis users in Nigeria.

Nelson EE, Essien NF.

J Subst Abuse Treat. 2021 Jun;125:108321. doi: 10.1016/j.jsat.2021.108321. Epub 2021 Feb 4.

PMID: 34016304

186. UK IBD Twin Registry: Concordance and Environmental Risk Factors of Twins with IBD.

Gordon H, Blad W, Trier Møller F, Orchard T, Steel A, Trevelyan G, Ng S, Harbord M.

Dig Dis Sci. 2021 Jun 7. doi: 10.1007/s10620-021-07080-5. Online ahead of print.

PMID: 34097167

187. Availability of medical cannabis dispensaries and cannabis abuse/dependence-related hospitalizations in California.

Mair C, Sumetsky N, Kranich C, Freisthler B.

Addiction. 2021 Jul;116(7):1908-1913. doi: 10.1111/add.15420. Epub 2021 Feb 10.

PMID: 33565655

188. Cannabis Seeds Authentication by Chloroplast and Nuclear DNA Analysis Coupled with High-Resolution Melting Method for Quality Control Purposes.

Anabalón L, Solano J, Encina-Montoya F, Bustos M, Figueroa A, Gangitano D.

Cannabis Cannabinoid Res. 2021 Jun 17. doi: 10.1089/can.2020.0168. Online ahead of print.

PMID: 34142864

189. Assessing the prevalence and correlates of prenatal cannabis consumption in an urban Canadian population: a cross-sectional survey.

Kaarid KP, Vu N, Bartlett K, Patel T, Sharma S, Honor RD, Shea AK.

CMAJ Open. 2021 Jun 23;9(2):E703-E710. doi: 10.9778/cmajo.20200181. Print 2021 Apr-Jun.

PMID: 34162662

190. Methamphetamine use and psychotic symptoms: findings from a New Zealand longitudinal birth cohort.

Boden JM, Foulds JA, Newton-Howes G, McKetin R.

Psychol Med. 2021 Jun 17:1-8. doi: 10.1017/S0033291721002415. Online ahead of print.

PMID: 34134802

191. Predoctoral substance use disorders curricula: A survey analysis and experiential pedagogy.

Odusola F, Kaufman J, Turrigiano E, Aydinoglo N, Shulman M, Kidd J, Hu MC, Levin FR.

J Dent Educ. 2021 Jun 11. doi: 10.1002/jdd.12697. Online ahead of print.

PMID: 34117646

192. Societal issues and policy implications related to the use of cannabinoids, cannabis, and cannabis-based medicines for pain management.

Haroutounian S, Gilron I, Belton J, Degenhardt L, Di Forti M, Finn DP, Fogarty A, Kalso E, Krane E, Moore RA, Rowbotham M, Wallace M, Rice ASC.

Pain. 2021 Jul 1;162(Suppl 1):S110-S116. doi: 10.1097/j.pain.0000000000002001.

PMID: 33009248 No abstract available.

193. Assessment of neuropsychological impairments in regular cannabis users.

Bechtel S, Lazar V, Albuisson E, Schwan R, Laprévote V, Bernardin F, Schwitzer T.

Encephale. 2021 Jun 3:S0013-7006(21)00113-5. doi: 10.1016/j.encep.2021.02.013. Online ahead of print.

PMID: 34092379

194. Are Sweet Dreams Made of These? Understanding the Relationship Between Sleep and Cannabis Use.

Edwards D, Filbey FM.

Cannabis Cannabinoid Res. 2021 Jun 18. doi: 10.1089/can.2020.0174. Online ahead of print.

PMID: 34143657

195. Associations of Current and Remitted Cannabis Use Disorder With Health-related Quality of Life and Employment Among US Adults.

Rhee TG, Rosenheck RA.

J Addict Med. 2021 Jun 17. doi: 10.1097/ADM.0000000000000889. Online ahead of print.

PMID: 34145190

196. Mental health treatment use among cannabis users aged 50+: Associations with cannabis use characteristics.

Choi NG, DiNitto DM, Phillips KT.

Drug Alcohol Depend. 2021 Jun 1;223:108705. doi: 10.1016/j.drugalcdep.2021.108705. Epub 2021 Apr 10.

PMID: 33862322

197. A latent class analysis of cannabis use products in a general population sample of adolescents and their association with paranoia, hallucinations, cognitive disorganisation and grandiosity.

Mackie CJ, Wilson J, Freeman TP, Craft S, Escamilla De La Torre T, Lynskey MT.

Addict Behav. 2021 Jun;117:106837. doi: 10.1016/j.addbeh.2021.106837. Epub 2021 Jan 21.

PMID: 33545621

198. Decrease in prevalence but increase in frequency of non-marijuana drug use following the onset of the COVID-19 pandemic in a large cohort of young men who have sex with men and young transgender women.

Janulis P, Newcomb ME, Mustanski B.

Drug Alcohol Depend. 2021 Jun 1;223:108701. doi: 10.1016/j.drugalcdep.2021.108701. Epub 2021 Apr 10.

PMID: 33865210

199. Endocannabinoids, Cannabinoids and the Regulation of Anxiety.

Petrie GN, Nastase AS, Aukema RJ, Hill MN.

Neuropharmacology. 2021 Jun 8:108626. doi: 10.1016/j.neuropharm.2021.108626. Online ahead of print.

PMID: 34116110

200. Traditional risk and cultural protection: Correlates of alcohol and cannabis co-use among African-American adolescents.

Banks DE, Riley TN, Bernard DL, Fisher S, Barnes-Najor J.

Psychol Addict Behav. 2021 Jun 7. doi: 10.1037/adb0000756. Online ahead of print.

PMID: 34096747

Items 1-168 of 168 (Display the 168 citations in PubMed)

1. Longitudinal trajectories of E-cigarette use among adolescents: A 5-year, multiple cohort study of vaping with and without marijuana.

Harrell MB, Chen B, Clendennen SL, Sumbe A, Case KR, Wilkinson AV, Loukas A, Perry CL.

Prev Med. 2021 Jun 1;150:106670. doi: 10.1016/j.ypmed.2021.106670. Online ahead of print.

PMID: 34087321

2. Depression, anxiety, and drug usage history indicators among institutionalized juvenile offenders of Brasilia.

da Silva MC, Cruz APM, Teixeira MO.

Psicol Reflex Crit. 2021 Jun 22;34(1):17. doi: 10.1186/s41155-021-00184-x.

PMID: 34156567

3. Hempseed (Cannabis sativa) offers effective alternative over statins in ameliorating hypercholesterolemia associated nephropathy.

Kaur S, Garg A, Kaushal N.

Clin Biochem. 2021 Jul;93:104-111. doi: 10.1016/j.clinbiochem.2021.04.008. Epub 2021 Apr 20.

PMID: 33861983

4. Health Claims About Cannabidiol Products: A Retrospective Analysis of U.S. Food and Drug Administration Warning Letters from 2015 to 2019.

Wagoner KG, Lazard AJ, Romero-Sandoval EA, Reboussin BA.

Cannabis Cannabinoid Res. 2021 Jun 17. doi: 10.1089/can.2020.0166. Online ahead of print.

PMID: 34142863

5. Cross national comparison of medical students’ attitudes and beliefs about medical cannabis and its application for pain management.

Likhitsathian S, Edelstein OE, Srisurapanont M, Zolotov Y, Karawekpanyawong N, Reznik A, Isralowitz R.

Complement Ther Med. 2021 Jun;59:102720. doi: 10.1016/j.ctim.2021.102720. Epub 2021 Apr 14.

PMID: 33864906

6. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls.

Avcioglu G, Yilmaz G, Yalcin Sahiner S, Kozaci LD, Bal C, Yilmaz FM.

Clin Biochem. 2021 Jul;93:112-118. doi: 10.1016/j.clinbiochem.2021.04.009. Epub 2021 Apr 18.

PMID: 33882283

7. Tetrahydrocannabinol (THC)-containing e-cigarette, or vaping, product use behaviors among adults after the onset of the 2019 outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI).

Trivers KF, Watson CV, Neff LJ, Jones CM, Hacker K.

Addict Behav. 2021 Oct;121:106990. doi: 10.1016/j.addbeh.2021.106990. Epub 2021 May 14.

PMID: 34087764

8. A primer on medicinal cannabis safety and potential adverse effects.

Arnold JC.

Aust J Gen Pract. 2021 Jun;50(6):345-350. doi: 10.31128/AJGP-02-21-5845.

PMID: 34059837

9. Strong associations among PTSD, pain, and alcohol and drug use disorders in VA primary care patients.

Tiet QQ, Moos RH.

Drug Alcohol Depend. 2021 Jun 1;223:108699. doi: 10.1016/j.drugalcdep.2021.108699. Epub 2021 Apr 10.

PMID: 33862323

10. Biomechanical Effects of Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD), the Major Constituents of Cannabis, in a Sprague Dawley Rat Achilles Tendon Surgical Repair Model: A Pilot Study.

Stauch CM, Ammerman B, Sepulveda D, Aynardi MC, Garner MR, Lewis G, Morgan D, Dhawan A.

Am J Sports Med. 2021 Jun 7:3635465211016840. doi: 10.1177/03635465211016840. Online ahead of print.

PMID: 34097540

11. Evaluation of cannabidiol’s inhibitory effect on alpha-glucosidase and its stability in simulated gastric and intestinal fluids.

Ma H, Li H, Liu C, Seeram NP.

J Cannabis Res. 2021 Jun 23;3(1):20. doi: 10.1186/s42238-021-00077-x.

PMID: 34162444

12. Parent SMART (Substance Misuse in Adolescents in Residential Treatment): Pilot randomized trial of a technology-assisted parenting intervention.

Becker SJ, Helseth SA, Janssen T, Kelly LM, Escobar KI, Souza T, Wright T, Spirito A.

J Subst Abuse Treat. 2021 Aug;127:108457. doi: 10.1016/j.jsat.2021.108457. Epub 2021 Apr 30.

PMID: 34134877

13. Interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity.

Fish S, Christidi F, Karavasilis E, Velonakis G, Kelekis N, Klein C, Stefanis NC, Smyrnis N.

NPJ Schizophr. 2021 Jun 16;7(1):33. doi: 10.1038/s41537-021-00163-2.

PMID: 34135344

14. Delay discounting and neurocognitive performance in young adults with differential patterns of substance use: Findings from the Human Connectome Project.

Naudé GP, Strickland JC, Reed DD, Amlung M.

Exp Clin Psychopharmacol. 2021 Jun 3. doi: 10.1037/pha0000469. Online ahead of print.

PMID: 34081511

15. Lateral habenula cannabinoid CB1 receptor involvement in drug-associated impulsive behavior.

Zapata A, Lupica CR.

Neuropharmacology. 2021 Jul 1;192:108604. doi: 10.1016/j.neuropharm.2021.108604. Epub 2021 May 7.

PMID: 33965396

16. Longitudinal Effects of Peer, School, and Parenting Contexts on Substance Use Initiation in Middle Adolescence.

Ladis B, Trucco EM, Huang H, Thomlison B, Fava NM.

J Evid Based Soc Work (2019). 2021 Jun 7:1-19. doi: 10.1080/26408066.2021.1932660. Online ahead of print.

PMID: 34096482

17. Fatal intoxication related to two new arylcyclohexylamine derivatives (2F-DCK and 3-MeO-PCE).

Gicquel T, Richeval C, Mesli V, Gish A, Hakim F, Pelletier R, Cornez R, Balgairies A, Allorge D, Gaulier JM.

Forensic Sci Int. 2021 Jul;324:110852. doi: 10.1016/j.forsciint.2021.110852. Epub 2021 May 23.

PMID: 34049075

18. Treating Insomnia Symptoms with Medicinal Cannabis: A Randomized, Cross-Over Trial of the Efficacy of a Cannabinoid Medicine Compared with Placebo.

Walsh JH, Maddison KJ, Rankin T, Murray K, McArdle N, Ree MJ, Hillman DR, Eastwood PR.

Sleep. 2021 Jun 11:zsab149. doi: 10.1093/sleep/zsab149. Online ahead of print.

PMID: 34115851

19. Cannabis Product Ingestions in Pediatric Patients: Ranges of Exposure, Effects, and Outcomes.

Kaczor EE, Mathews B, LaBarge K, Chapman BP, Carreiro S.

J Med Toxicol. 2021 Jun 11. doi: 10.1007/s13181-021-00849-0. Online ahead of print.

PMID: 34117620

20. Cannabis use companions’ gender and sexual orientation: Associations with problematic cannabis use in a sample of sexual minorities assigned female at birth.

Dyar C, Feinstein BA, Newcomb ME, Whitton SW.

Addict Behav. 2021 Jul;118:106878. doi: 10.1016/j.addbeh.2021.106878. Epub 2021 Feb 22.

PMID: 33652333

21. Investigation of in vitro odonto/osteogenic capacity of cannabidiol on human dental pulp cell.

Qi X, Liu C, Li G, Luan H, Li S, Yang D, Zhou Z.

J Dent. 2021 Jun;109:103673. doi: 10.1016/j.jdent.2021.103673. Epub 2021 Apr 16.

PMID: 33872753

22. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects.

Sartim AG, Marques J, Silveira KM, Gobira PH, Guimarães FS, Wegener G, Joca SR.

Neuropharmacology. 2021 Jun 19:108679. doi: 10.1016/j.neuropharm.2021.108679. Online ahead of print.

PMID: 34157363

23. Accurate and sufficient measurement of cannabis and tobacco co-use: agreement, consensus and the path forward.

McClure EA.

Addiction. 2021 Jul;116(7):1636-1637. doi: 10.1111/add.15497. Epub 2021 Apr 14.

PMID: 33855758 No abstract available.

24. Monoacylglycerol Lipase Inhibition Using JZL184 Attenuates Paw Inflammation and Functional Deficits in a Mouse Model of Inflammatory Arthritis.

Nass SR, Steele FF, Ware TB, Libby AH, Hsu KL, Kinsey SG.

Cannabis Cannabinoid Res. 2021 Jun;6(3):233-241. doi: 10.1089/can.2020.0177. Epub 2021 May 25.

PMID: 34042520

25. A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction.

Zylla DM, Eklund J, Gilmore G, Gavenda A, Guggisberg J, VazquezBenitez G, Pawloski PA, Arneson T, Richter S, Birnbaum AK, Dahmer S, Tracy M, Dudek A.

Support Care Cancer. 2021 Jun 4. doi: 10.1007/s00520-021-06301-x. Online ahead of print.

PMID: 34085149

26. Real-Time Imaging of Immune Modulation by Cannabinoids Using Intravital Fluorescence Microscopy.

Zhou J, Kamali K, Lafreniere JD, Lehmann C.

Cannabis Cannabinoid Res. 2021 Jun;6(3):221-232. doi: 10.1089/can.2020.0179. Epub 2021 May 27.

PMID: 34042507

27. Investigating sex differences in acute intoxication and verbal memory errors after ad libitum cannabis concentrate use.

Gibson LP, Gust CJ, Ellingson JM, YorkWilliams SL, Sempio C, Klawitter J, Bryan AD, Hutchison KE, Cinnamon Bidwell L.

Drug Alcohol Depend. 2021 Jun 1;223:108718. doi: 10.1016/j.drugalcdep.2021.108718. Epub 2021 Apr 20.

PMID: 33866072

28. Fact versus fiction: bridging contrasting medicinal cannabis information needs.

Philip J, Panozzo S, Collins A, Weil J, Whyte J, Barton M, Coperchini M, Rametta M, Le B.

Intern Med J. 2021 Jun;51(6):975-979. doi: 10.1111/imj.15361.

PMID: 34155769

29. Associations of cannabis use frequency and cannabis use disorder with receiving a substance use screen and healthcare professional discussion of substance use.

Moore JR, DiNitto DM, Choi NG.

Am J Addict. 2021 Jun 18. doi: 10.1111/ajad.13195. Online ahead of print.

PMID: 34143567

30. Effect of Washington State and Colorado’s cannabis legalization on death by suicides.

Doucette ML, Borrup KT, Lapidus G, Whitehill JM, McCourt AD, Crifasi CK.

Prev Med. 2021 Jul;148:106548. doi: 10.1016/j.ypmed.2021.106548. Epub 2021 Apr 8.

PMID: 33838156

31. Adverse effects of heavy cannabis use: even plants can harm the brain.

Sideli L, Trotta G, Spinazzola E, La Cascia C, Di Forti M.

Pain. 2021 Jul 1;162(Suppl 1):S97-S104. doi: 10.1097/j.pain.0000000000001963.

PMID: 32804835 No abstract available.

32. Experiencing Bullying Is Associated With Firearm Access, Weapon Carriage, Depression, Marijuana Use, and Justice Involvement in Adolescents.

Donnelly KA, Rucker A, Boyle MD, Fornari MJ, Badolato GM, Goyal MK.

Pediatr Emerg Care. 2021 Jun 11. doi: 10.1097/PEC.0000000000002473. Online ahead of print.

PMID: 34116552

33. Systematic review and meta-analysis of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent pain.

Soliman N, Haroutounian S, Hohmann AG, Krane E, Liao J, Macleod M, Segelcke D, Sena C, Thomas J, Vollert J, Wever K, Alaverdyan H, Barakat A, Barthlow T, Bozer ALH, Davidson A, Diaz-delCastillo M, Dolgorukova A, Ferdousi MI, Healy C, Hong S, Hopkins M, James A, Leake HB, Malewicz NM, Mansfield M, Mardon AK, Mattimoe D, McLoone DP, Noes-Holt G, Pogatzki-Zahn EM, Power E, Pradier B, Romanos-Sirakis E, Segelcke A, Vinagre R, Yanes JA, Zhang J, Zhang XY, Finn DP, Rice ASC.

Pain. 2021 Jul 1;162(Suppl 1):S26-S44. doi: 10.1097/j.pain.0000000000002269.

PMID: 33729209

34. Neurodevelopmental Effects of Cannabis Use in Adolescents and Emerging Adults with ADHD: A Systematic Review.

Cawkwell PB, Hong DS, Leikauf JE.

Harv Rev Psychiatry. 2021 Jun 16. doi: 10.1097/HRP.0000000000000303. Online ahead of print.

PMID: 34138796

35. Medical Cannabis.

[No authors listed]

J Hosp Palliat Nurs. 2021 Jun 1;23(3):E11-E13. doi: 10.1097/NJH.0000000000000751.

PMID: 33911061 No abstract available.

36. [Legal access to cannabis and pilot projects in Switzerland].

Cattacin S.

Rev Med Suisse. 2021 Jun 9;17(742):1106-1107.

PMID: 34106533 French.

37. Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis.

Aviram J, Lewitus GM, Pud D, Procaccia S, Berman P, Yellin B, Vysotski Y, Hazan O, Eisenberg E, Meiri D.

Pharmacol Res. 2021 Jul;169:105651. doi: 10.1016/j.phrs.2021.105651. Epub 2021 May 15.

PMID: 34000362

38. Momentary versus retrospective reports of alcohol or cannabis use, sexual activity, and their co-occurrence.

Willis M, Marcantonio TL, Jozkowski KN.

Addict Behav. 2021 Aug;119:106932. doi: 10.1016/j.addbeh.2021.106932. Epub 2021 Mar 26.

PMID: 33892310

39. Prevalence of cannabis use, disorder, and medical card possession in U.S. military veterans: Results from the 2019-2020 National Health and Resilience in Veterans Study.

Hill ML, Loflin M, Nichter B, Norman SB, Pietrzak RH.

Addict Behav. 2021 Sep;120:106963. doi: 10.1016/j.addbeh.2021.106963. Epub 2021 Apr 27.

PMID: 33964583

40. Cannabinoid receptor agonists from Conus venoms alleviate pain-related behavior in rats.

Jergova S, Perez C, Imperial JS, Gajavelli S, Jain A, Abin A, Olivera BM, Sagen J.

Pharmacol Biochem Behav. 2021 Jun;205:173182. doi: 10.1016/j.pbb.2021.173182. Epub 2021 Mar 25.

PMID: 33774007

41. Haloperidol Use in the Emergency Department for Gastrointestinal Symptoms: Nausea, Vomiting, and Abdominal Pain.

Shahsavari D, Reznick-Lipina K, Malik Z, Weiner M, Jehangir A, Repanshek ZD, Parkman HP.

Clin Transl Gastroenterol. 2021 Jun 1;12(6):e00362. doi: 10.14309/ctg.0000000000000362.

PMID: 34060494 Free PMC article.

42. The association of opioid use disorder and homelessness nationally in the veterans health administration.

Manhapra A, Stefanovics E, Rosenheck R.

Drug Alcohol Depend. 2021 Jun 1;223:108714. doi: 10.1016/j.drugalcdep.2021.108714. Epub 2021 Apr 14.

PMID: 33865213

43. Changes in young adult substance use during COVID-19 as a function of ACEs, depression, prior substance use and resilience.

Romm KF, Patterson B, Crawford ND, Posner H, West CD, Wedding D, Horn K, Berg CJ.

Subst Abus. 2021 Jun 4:1-24. doi: 10.1080/08897077.2021.1930629. Online ahead of print.

PMID: 34086537

44. Initial evaluation of domain-specific episodic future thinking on delay discounting and cannabis use.

Sofis MJ, Lemley SM, Jacobson NC, Budney AJ.

Exp Clin Psychopharmacol. 2021 Jun 7. doi: 10.1037/pha0000501. Online ahead of print.

PMID: 34096759

45. Treatment retention and abstinence of patients with substance use disorders according to addiction severity and psychiatry comorbidity: A six-month follow-up study in an outpatient unit.

Daigre C, Rodríguez L, Roncero C, Palma-Álvarez RF, Perea-Ortueta M, Sorribes-Puertas M, Martínez-Luna N, Ros-Cucurull E, Ramos-Quiroga JA, Grau-López L.

Addict Behav. 2021 Jun;117:106832. doi: 10.1016/j.addbeh.2021.106832. Epub 2021 Jan 20.

PMID: 33529849

46. Repetitive transcranial magnetic stimulation as a potential treatment approach for cannabis use disorder.

Kearney-Ramos T, Haney M.

Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jul 13;109:110290. doi: 10.1016/j.pnpbp.2021.110290. Epub 2021 Mar 4.

PMID: 33677045 Review.

47. Marijuana use disorder and arrhythmias: what were they smoking?

Olshansky B.

Europace. 2021 Jun 10:euab135. doi: 10.1093/europace/euab135. Online ahead of print.

PMID: 34109381 No abstract available.

48. Illicit Substance Use Disparities Among Lesbian, Gay, and Bisexual High School Students in the U.S. in 2017.

Fernandez J, Gonzalez R, Oves JC Jr, Rodriguez P, Castro G, Barengo NC.

J Adolesc Health. 2021 Jun;68(6):1170-1175. doi: 10.1016/j.jadohealth.2021.02.004. Epub 2021 Apr 2.

PMID: 33814276

49. Event-level patterns of methamphetamine and poly-drug use among millennial sexual minority men: The P18 Cohort Study.

Martino RJ, Shiau S, Krause KD, Halkitis PN.

Addict Behav. 2021 Jun;117:106831. doi: 10.1016/j.addbeh.2021.106831. Epub 2021 Jan 19.

PMID: 33588290

50. Characterization of chemotype-dependent terpenoids profile in cannabis by headspace gas-chromatography coupled to time-of-flight mass spectrometry.

Dei Cas M, Arnoldi S, Monguzzi L, Casagni E, Morano C, Vieira de Manincor E, Bolchi C, Pallavicini M, Gambaro V, Roda G.

J Pharm Biomed Anal. 2021 Jun 1;203:114180. doi: 10.1016/j.jpba.2021.114180. Online ahead of print.

PMID: 34111731

51. Preoperative Considerations for Teenagers Undergoing Orthopaedic Surgery: VTE Prevention, Mental Health Assessment, Vaping, and Drug Addiction.

Shore BJ, Flaugh R, Shannon BA, Curran P, Hogue G.

J Pediatr Orthop. 2021 Jul 1;41(Suppl 1):S64-S69. doi: 10.1097/BPO.0000000000001764.

PMID: 34096540

52. Persistence of Δ-9-Tetrahydrocannabinol in Human Breast Milk.

Wymore EM, Palmer C, Wang GS, Metz TD, Bourne DWA, Sempio C, Bunik M.

JAMA Pediatr. 2021 Jun 1;175(6):632-634. doi: 10.1001/jamapediatrics.2020.6098.

PMID: 33683306

53. What influences demand for cigars among African American adult cigar smokers? Results from a hypothetical purchase task.

Simuzingili M, Hoetger C, Garner W, Everhart RS, Hood KB, Nana-Sinkam P, Cobb CO, Barnes AJ.

Exp Clin Psychopharmacol. 2021 Jun 10. doi: 10.1037/pha0000491. Online ahead of print.

PMID: 34110888

54. Legalization of cannabis use in Canada: Impacts on the cannabis use profiles of youth seeking services for substance use.

Hawke LD, Henderson J.

J Subst Abuse Treat. 2021 Jul;126:108340. doi: 10.1016/j.jsat.2021.108340. Epub 2021 Feb 25.

PMID: 34116825

55. Cannabis and Inflammatory Bowel Disease: All Smoke and Mirrors?

Gianotti RJ, Cheifetz AS.

J Crohns Colitis. 2021 Jun 17:jjab091. doi: 10.1093/ecco-jcc/jjab091. Online ahead of print.

PMID: 34137450 No abstract available.

56. A cross-national examination of cannabis protective behavioral strategies’ role in the relationship between Big Five personality traits and cannabis outcomes.

Herchenroeder L, Mezquita L, Bravo AJ, Pilatti A, Prince MA, Study Team CA.

Am J Drug Alcohol Abuse. 2021 Jun 16:1-11. doi: 10.1080/00952990.2021.1919689. Online ahead of print.

PMID: 34134573

57. The relations between discrimination, stressful life events, and substance use among adults experiencing homelessness: Stress and substance use among homeless adults.

Alexander AC, Waring JJC, Olurotimi O, Kurien J, Noble B, Businelle MS, Ra CK, Ehlke SJ, Boozary LK, Cohn AM, Kendzor DE.

Stress Health. 2021 Jun 16. doi: 10.1002/smi.3073. Online ahead of print.

PMID: 34137166

58. Cannabis use of patients with inflammatory bowel disease in Germany: a cross-sectional survey.

Neufeld T, Pfuhlmann K, Stock-Schröer B, Kairey L, Bauer N, Häuser W, Langhorst J.

Z Gastroenterol. 2021 Jun 22. doi: 10.1055/a-1400-2768. Online ahead of print.

PMID: 34157755 English.

59. Investigation of patterns and dynamics of substance users: A long-term toxicology study on a sample of the Greek population between 2005 and 2019.

Karakasi MV, Kevrekidis DP, Voultsos P, Trypsiannis G, Manolopoulos VG, Raikos N, Pavlidis P.

J Forensic Sci. 2021 Jun 15. doi: 10.1111/1556-4029.14776. Online ahead of print.

PMID: 34128547

60. Cigarette Smokers Versus Cannabis Smokers Versus Co-users of Cigarettes and Cannabis: A Pilot Study Examining Exposure to Toxicants.

Meier E, Tessier KM, Luo X, Dick L, Thomson NM, Hecht SS, Carmella SG, Murphy S, Hatsukami DK.

Nicotine Tob Res. 2021 Jun 12:ntab125. doi: 10.1093/ntr/ntab125. Online ahead of print.

PMID: 34120176

61. A Rebuttal-Based Social Norms-Tailored Cannabis Intervention for At-Risk Adolescents.

Donaldson CD, Alvaro EM, Ruybal AL, Coleman M, Siegel JT, Crano WD.

Prev Sci. 2021 Jul;22(5):609-620. doi: 10.1007/s11121-021-01224-9. Epub 2021 Apr 1.

PMID: 33791930

62. Physicochemical, functional and bioactive properties of hempseed (Cannabis sativa L.) meal, a co-product of hempseed oil and protein production, as affected by drying process.

Lin Y, Pangloli P, Dia VP.

Food Chem. 2021 Jul 15;350:129188. doi: 10.1016/j.foodchem.2021.129188. Epub 2021 Feb 5.

PMID: 33588280

63. Impact of COVID-19 lockdown on individuals under treatment for substance use disorders: Risk factors for adverse mental health outcomes.

Blithikioti C, Nuño L, Paniello B, Gual A, Miquel L.

J Psychiatr Res. 2021 Jul;139:47-53. doi: 10.1016/j.jpsychires.2021.05.006. Epub 2021 May 8.

PMID: 34029833

64. Onset of substance use: Deviant peer, sex, and sympathetic nervous system predictors.

Hinnant JB, Gillis BT, Erath SA, El-Sheikh M.

Dev Psychopathol. 2021 Jun 8:1-10. doi: 10.1017/S0954579421000158. Online ahead of print.

PMID: 34099087

65. Cannabidiol prevents several of the behavioral alterations related to cocaine addiction in mice.

Ledesma JC, Manzanedo C, Aguilar MA.

Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jun 19:110390. doi: 10.1016/j.pnpbp.2021.110390. Online ahead of print.

PMID: 34157334

66. Discrimination of CBD-, THC- and CBC-type acid cannabinoids through diagnostic ions by UHPLC-HR-MS/MS in negative ion mode.

Piccolella S, Formato M, Pecoraro MT, Crescente G, Pacifico S.

J Pharm Biomed Anal. 2021 Jul 15;201:114125. doi: 10.1016/j.jpba.2021.114125. Epub 2021 May 5.

PMID: 33989997

67. Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada.

Lee C, Round JM, Klarenbach S, Hanlon JG, Hyshka E, Dyck JRB, Eurich DT.

Harm Reduct J. 2021 Jun 8;18(1):61. doi: 10.1186/s12954-021-00509-0.

PMID: 34103058 Free PMC article.

68. Effectiveness of attentional bias modification training as add-on to regular treatment in alcohol and cannabis use disorder: A multicenter randomized control trial.

Heitmann J, van Hemel-Ruiter ME, Huisman M, Ostafin BD, Wiers RW, MacLeod C, DeFuentes-Merillas L, Fledderus M, Markus W, de Jong PJ.

PLoS One. 2021 Jun 4;16(6):e0252494. doi: 10.1371/journal.pone.0252494. eCollection 2021.

PMID: 34086751 Free PMC article.

69. A Family-Based Healthy Lifestyle Intervention: Crossover Effects on Substance Use and Sexual Risk Behaviors.

Fernandez A, Lozano A, Lee TK, Estrada Y, Messiah SE, Prado G.

Prev Sci. 2021 Jul;22(5):602-608. doi: 10.1007/s11121-021-01220-z. Epub 2021 Mar 10.

PMID: 33689118

70. Response to Canadian Psychiatric Association Cannabinoid Products Position Statement: Potential for Ameliorating Cannabis Withdrawal.

Bahji A.

Can J Psychiatry. 2021 Jun;66(6):586-587. doi: 10.1177/0706743720976452. Epub 2020 Dec 2.

PMID: 33998318 No abstract available.

71. New perspective for the in-field analysis of cannabis samples using handheld near-infrared spectroscopy: A case study focusing on the determination of Δ9-tetrahydrocannabinol.

Deidda R, Coppey F, Damergi D, Schelling C, Coïc L, Veuthey JL, Sacré PY, De Bleye C, Hubert P, Esseiva P, Ziemons É.

J Pharm Biomed Anal. 2021 Aug 5;202:114150. doi: 10.1016/j.jpba.2021.114150. Epub 2021 May 19.

PMID: 34034047

72. A multi-site study of emerging adults in collegiate recovery programs at public institutions.

Hennessy EA, Tanner-Smith EE, Nichols LM, Brown TB, Mcculloch BJ.

Soc Sci Med. 2021 Jun;278:113955. doi: 10.1016/j.socscimed.2021.113955. Epub 2021 Apr 23.

PMID: 33940434

73. Moderated Mediation of the eCHECKUP TO GO College Student Cannabis Use Intervention.

Fetterling T, Parnes J, Prince MA, Conner BT, George MW, Shillington AM, Riggs NR.

Subst Use Misuse. 2021 Jun 14:1-8. doi: 10.1080/10826084.2021.1937225. Online ahead of print.

PMID: 34126858

74. Politics of the natural vegetation to balance the hazardous level of elements in marble polluted ecosystem through phytoremediation and physiological responses.

Ahmad Z, Khan SM, Page S.

J Hazard Mater. 2021 Jul 15;414:125451. doi: 10.1016/j.jhazmat.2021.125451. Epub 2021 Feb 20.

PMID: 34030399

75. “When I Take Drugs, I Don’t Care”: Insights into the Operational Dynamics of Male Violent Offenders in a Correctional Centre.

Nnam MU, Ordu GE, Eteng MJ, Ukah JA, Arua CC, Okechukwu GP, Obasi CO.

Int J Offender Ther Comp Criminol. 2021 Jun 6:306624X211022653. doi: 10.1177/0306624X211022653. Online ahead of print.

PMID: 34096346

76. Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting.

Rock EM, Limebeer CL, Pertwee RG, Mechoulam R, Parker LA.

Cannabis Cannabinoid Res. 2021 Jun 11. doi: 10.1089/can.2021.0041. Online ahead of print.

PMID: 34115951

77. Fool’s gold: diseased marijuana and cannabis hyperemesis syndrome.

Dorantes OA.

J Investig Med. 2021 Jun;69(5):1063-1064. doi: 10.1136/jim-2021-001980.

PMID: 34074707 No abstract available.

78. Cannabinoid Receptor Subtype-1 Regulates Allergic Airway Eosinophilia During Lung Helminth Infection.

Wiley MB, Bobardt SD, Nordgren TM, Nair MG, DiPatrizio NV.

Cannabis Cannabinoid Res. 2021 Jun;6(3):242-252. doi: 10.1089/can.2020.0167. Epub 2021 Apr 8.

PMID: 33998896

79. Local variation in cannabis use patterns among young adults in the San Francisco Bay Area.

Holmes LM, Thrul J, Warren NK, Ling PM.

Spat Spatiotemporal Epidemiol. 2021 Jun;37:100418. doi: 10.1016/j.sste.2021.100418. Epub 2021 Mar 17.

PMID: 33980412

80. Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial.

Fishman M, Wenzel K, Scodes J, Pavlicova M, Campbell ANC, Rotrosen J, Nunes E.

Am J Addict. 2021 Jun 1. doi: 10.1111/ajad.13176. Online ahead of print.

PMID: 34075644

81. A comparison of cannabis protective behavioral strategies use across cultures and sex.

Richards DK, Schwebel FJ, Bravo AJ, Pearson MR; Cross-Cultural Addictions Study Team.

Addict Behav. 2021 Sep;120:106966. doi: 10.1016/j.addbeh.2021.106966. Epub 2021 Apr 28.

PMID: 34020169

82. Profile of patients attending psychiatric emergency care during the coronavirus 2019 (COVID 19) pandemic: a comparative cross-sectional study between lockdown and post-lockdown periods in Lombardy, Italy.

Capuzzi E, Caldiroli A, Di Brita C, Colmegna F, Nava R, Colzani LC, Sibilla M, Prodi T, Buoli M, Clerici M.

Int J Psychiatry Clin Pract. 2021 Jun 21:1-7. doi: 10.1080/13651501.2021.1939385. Online ahead of print.

PMID: 34151680

83. Response to ‘Fool’s gold: diseased marijuana and cannabis hyperemesis syndrome’.

McCallum R.

J Investig Med. 2021 Jun;69(5):1065-1066. doi: 10.1136/jim-2021-001982.

PMID: 34074708 No abstract available.

84. Factor analysis of a short form of the Protective Behavioral Strategies for Marijuana scale.

Mian MN, Altman BR, Luba R, Ueno LF, Dalal D, Earleywine M.

Addict Behav. 2021 Jun;117:106852. doi: 10.1016/j.addbeh.2021.106852. Epub 2021 Feb 4.

PMID: 33581678

85. Prevalence of positive toxicology analysis from the French national registry for sudden unexpected infant death (Tox-MIN).

Claudet I, de Visme S, Duthoit G, Barnet L, Marchand-Tonel C, Chever M, Daussac E, Bréhin C, Levieux K; OMIN Study Group.

Clin Toxicol (Phila). 2021 Jun 3:1-8. doi: 10.1080/15563650.2021.1933005. Online ahead of print.

PMID: 34080518

86. Drum-Assisted Recovery Therapy for Native Americans (DARTNA): Results from a feasibility randomized controlled trial.

Dickerson DL, D’Amico EJ, Klein DJ, Johnson CL, Hale B, Ye F, Dominguez BX.

J Subst Abuse Treat. 2021 Jul;126:108439. doi: 10.1016/j.jsat.2021.108439. Epub 2021 Apr 28.

PMID: 33966952

87. Why should we ask binge drinkers if they smoke cannabis? Additive effect of alcohol and cannabis use on college students’ neuropsychological performance.

Deniel S, Mauduy M, Cheam-Bernière C, Mauny N, Montcharmont C, Cabé N, Bazire A, Mange J, Le Berre AP, Jacquet D, Bagneux V, Leconte P, Ritz L, Beaunieux H.

Addict Behav Rep. 2021 Jun 8;14:100362. doi: 10.1016/j.abrep.2021.100362. eCollection 2021 Dec.

PMID: 34159250 Free PMC article.

88. Food Insecurity Partially Mediates the Association Between Drug Use and Depressive Symptoms among Men who have Sex with Men in Los Angeles, California.

Wiss DA, Javanbakht M, Li MJ, Prelip M, Bolan R, Shoptaw S, Gorbach PM.

Public Health Nutr. 2021 Jun 9:1-26. doi: 10.1017/S1368980021002494. Online ahead of print.

PMID: 34103117

89. Daily cannabis use in adolescents who smoke tobacco is associated with altered late-stage feedback processing: A high-density electrical mapping study.

Morie KP, Wu J, Potenza MN, Krishnan-Sarin S, Mayes LC, Hammond CJ, Crowley MJ.

J Psychiatr Res. 2021 Jul;139:82-90. doi: 10.1016/j.jpsychires.2021.05.022. Epub 2021 May 23.

PMID: 34052575

90. Marijuana, Breastfeeding, and the Use of Human Milk: Position Statement #3071.

Wallman C, Baessler C, Hoffman JM.

Adv Neonatal Care. 2021 Jun 1;21(3):176-177. doi: 10.1097/ANC.0000000000000904.

PMID: 34010855 No abstract available.

91. Factors Associated With Cannabis Use During the Reproductive Cycle: A Retrospective Cross-Sectional Study of Women in States With Recreational and Medical Cannabis Legalization.

Taylor DL, Bell JF, Adams SL, Drake C.

Matern Child Health J. 2021 Jun 21. doi: 10.1007/s10995-021-03197-1. Online ahead of print.

PMID: 34155601

92. Maltese Health and Social Wellbeing Student Knowledge, Attitudes and Beliefs about Medical Cannabis.

Bonnici J, Clark M.

Complement Ther Med. 2021 Jun 14:102753. doi: 10.1016/j.ctim.2021.102753. Online ahead of print.

PMID: 34139340

93. Pediatric Cannabis Single-Substance Exposures Reported to the Michigan Poison Center From 2008-2019 After Medical Marijuana Legalization.

Dean D, Passalacqua KD, Oh SM, Aaron C, Van Harn MG, King A.

J Emerg Med. 2021 Jun;60(6):701-708. doi: 10.1016/j.jemermed.2020.12.028. Epub 2021 Feb 2.

PMID: 33541760

94. Adolescent Work Values and Drug Use in Adulthood: A Longitudinal Prospective Cohort Study.

Takano A, Fukasawa M, Watanabe K, Nishi D, Kawakami N.

Subst Use Misuse. 2021 Jun 14:1-10. doi: 10.1080/10826084.2021.1936055. Online ahead of print.

PMID: 34120563

95. Nonadherence after hospital discharge in patients with schizophrenia or schizoaffective disorder: A six-month naturalistic follow-up study.

Vega D, Acosta FJ, Saavedra P.

Compr Psychiatry. 2021 Jul;108:152240. doi: 10.1016/j.comppsych.2021.152240. Epub 2021 Apr 17.

PMID: 33873014

96. Phytocannabinomics: Untargeted metabolomics as a tool for cannabis chemovar differentiation.

Cerrato A, Citti C, Cannazza G, Capriotti AL, Cavaliere C, Grassi G, Marini F, Montone CM, Paris R, Piovesana S, Laganà A.

Talanta. 2021 Aug 1;230:122313. doi: 10.1016/j.talanta.2021.122313. Epub 2021 Mar 20.

PMID: 33934778

97. Clinical prediction of extra-medical use of prescription pain relievers from a representative United States sample.

Thompson CL, Alcover KC, Yip SW.

Prev Med. 2021 Aug;149:106610. doi: 10.1016/j.ypmed.2021.106610. Epub 2021 May 11.

PMID: 33989674

98. Substance use is associated with worse mental health and altered resting state functional connectivity in female university athletes at baseline: A pilot study.

Wilson A, Gicas K, Stevens WD, Sergio L, Wojtowicz M.

PLoS One. 2021 Jun 17;16(6):e0253261. doi: 10.1371/journal.pone.0253261. eCollection 2021.

PMID: 34138920

99. Traduction française, adaptation culturelle et évaluation des propriétés psychométriques préliminaires de l’échelle des stratégies de protection comportementale liées à la consommation de cannabis: French translation, cultural adaptation and assessment of preliminary psychometric properties of the Protective Behavioral Strategies for Marijuana Scale.

José C, Patricia A, Gabrielle PM, Sylvie C, Stephanie CM, Guillaume F, Gabrielle C, Geneviève R, Christine G, Judith L, Didier JA.

Can J Psychiatry. 2021 Jun 23:7067437211025216. doi: 10.1177/07067437211025216. Online ahead of print.

PMID: 34160302

100. Simple chemical tests to identify Cannabis derivatives: Redefinition of parameters and analysis of concepts.

Grijó DR, Olivo JE, da Motta Lima OC.

J Forensic Sci. 2021 Jun 18. doi: 10.1111/1556-4029.14777. Online ahead of print.

PMID: 34142715

101. Anesthesia for Patients Who Self-Report Cannabis (Marijuana) Use Before Esophagogastroduodenoscopy: A Retrospective Review.

King DD, Stewart SA, Collins-Yoder A, Fleckner T, Price LL.

AANA J. 2021 Jun;89(3):205-212.

PMID: 34042571

102. Cocaine-induced Fos expression in the rat brain: Modulation by prior Δ9-tetrahydrocannabinol exposure during adolescence and sex-specific effects.

Orihuel J, Gómez-Rubio L, Valverde C, Capellán R, Roura-Martínez D, Ucha M, Ambrosio E, Higuera-Matas A.

Brain Res. 2021 Aug 1;1764:147480. doi: 10.1016/j.brainres.2021.147480. Epub 2021 Apr 20.

PMID: 33861997

103. Medicinal cannabis use in palliative care.

Herbert A, Hardy J.

Aust J Gen Pract. 2021 Jun;50(6):363-368. doi: 10.31128/AJGP-02-21-5831.

PMID: 34059839

104. Medium-throughput zebrafish optogenetic platform identifies deficits in subsequent neural activity following brief early exposure to cannabidiol and Δ9-tetrahydrocannabinol.

Kanyo R, Amin MR, Locskai LF, Bouvier DD, Olthuis AM, Allison WT, Ali DW.

Sci Rep. 2021 Jun 1;11(1):11515. doi: 10.1038/s41598-021-90902-3.

PMID: 34075141 Free PMC article.

105. Characteristics of electronic cigarette user and traditional smokers: 2017 Youth risk behavior surveillance system.

Lee YS, Yang K, Kameg B, Palmer J, Lee H.

Public Health Nurs. 2021 Jun 8. doi: 10.1111/phn.12936. Online ahead of print.

PMID: 34101886

106. CBG, CBD, Δ9-THC, CBN, CBGA, CBDA and Δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action.

Dawidowicz AL, Olszowy-Tomczyk M, Typek R.

Fitoterapia. 2021 Jul;152:104915. doi: 10.1016/j.fitote.2021.104915. Epub 2021 May 6.

PMID: 33964342

107. Testing the dual process model of adolescent cannabis use with prospective three-way interactions between self-regulation, negative outcome expectancies, and implicit cannabis attitudes.

Egerton GA, Colder CR, Lee Y.

Addict Behav. 2021 Jul;118:106902. doi: 10.1016/j.addbeh.2021.106902. Epub 2021 Mar 10.

PMID: 33756299

108. Impact of cannabis use on outcomes of patients admitted to an involuntary psychiatric unit: A retrospective cohort study.

Soler S, Montout C, Pepin B, Abbar M, Mura T, Lopez-Castroman J.

J Psychiatr Res. 2021 Jun;138:507-513. doi: 10.1016/j.jpsychires.2021.04.024. Epub 2021 Apr 30.

PMID: 33975067

109. Examining the impact of the early stages of the COVID-19 pandemic period on youth cannabis use: adjusted annual changes between the pre-COVID and initial COVID-lockdown waves of the COMPASS study.

Leatherdale ST, Bélanger RE, Gansaonré RJ, Patte KA, deGroh M, Jiang Y, Haddad S.

BMC Public Health. 2021 Jun 21;21(1):1181. doi: 10.1186/s12889-021-11241-6.

PMID: 34154564 Free PMC article.

110. Recreational cannabis use causing non-ischaemic cardiomyopathy and cardioembolism in a young adult.

Singh BO, Panda PK, Walia R.

BMJ Case Rep. 2021 Jun 1;14(6):e243193. doi: 10.1136/bcr-2021-243193.

PMID: 34078626

111. Impact of Florida’s prescription drug monitoring program on drug- related fatal vehicle crashes: a difference-in-differences approach.

Tatar M, Jalali MS, Tak HJ, Chen LW, Araz OM, Wilson FA.

Inj Prev. 2021 Jun 23:injuryprev-2020-044113. doi: 10.1136/injuryprev-2020-044113. Online ahead of print.

PMID: 34162702

112. Characteristics of fatal opioid overdoses with stimulant involvement in Tennessee: A descriptive study using 2018 State Unintentional Drug Overdose Reporting System Data.

Korona-Bailey JA, Nechuta S, Golladay M, Moses J, Bastasch O, Krishnaswami S.

Ann Epidemiol. 2021 Jun;58:149-155. doi: 10.1016/j.annepidem.2021.03.004. Epub 2021 Mar 17.

PMID: 33744415

113. Pre-incarceration polysubstance use involving opioids: A unique risk factor of postrelease return to substance use.

Bunting AM, Oser CB, Staton M, Knudsen HK.

J Subst Abuse Treat. 2021 Aug;127:108354. doi: 10.1016/j.jsat.2021.108354. Epub 2021 Mar 5.

PMID: 34134861

114. Internal and external sexual consent during events that involved alcohol, cannabis, or both.

Willis M, Marcantonio TL, Jozkowski KN.

Sex Health. 2021 Jun 17. doi: 10.1071/SH21015. Online ahead of print.

PMID: 34134817

115. Cannabis for Chronic Osteoarthritis Pain: A Case of an Older Person.

Griffin H, Fixen D.

Sr Care Pharm. 2021 Jul 1;36(7):337-342. doi: 10.4140/TCP.n.2021.337..

PMID: 34144723

116. Increasing cannabis use is associated with poorer cigarette smoking cessation outcomes: Findings from the ITC Four Country Smoking and Vaping Surveys, 2016-2018.

Driezen P, Gravely S, Wadsworth E, Smith DM, Loewen R, Hammond D, Li L, Abramovici H, McNeill A, Borland R, Cummings KM, Thompson ME, Fong GT.

Nicotine Tob Res. 2021 Jun 10:ntab122. doi: 10.1093/ntr/ntab122. Online ahead of print.

PMID: 34111281

117. Cognitive performance and lifetime cannabis use in patients with first-episode schizophrenia spectrum disorder.

Hájková M, Knížková K, Siroňová A, Keřková B, Jonáš J, Šustová P, Dorazilová A, Rodriguez M.

Cogn Neuropsychiatry. 2021 Jul;26(4):257-272. doi: 10.1080/13546805.2021.1924649. Epub 2021 May 11.

PMID: 33973827

118. Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contrary.

Feinstein A, Meza C, Stefan C, Staines WR.

Brain Behav. 2021 Jun 4. doi: 10.1002/brb3.2220. Online ahead of print.

PMID: 34087949

119. Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians.

Buckley MC, Kumar A, Swaminath A.

Adv Ther. 2021 Jun 10. doi: 10.1007/s12325-021-01805-8. Online ahead of print.

PMID: 34110607

120. [The green rush-worse than feared? : Data on the misuse of medical cannabis].

Maier C, Glaeske G.

Schmerz. 2021 Jun;35(3):185-187. doi: 10.1007/s00482-021-00560-7. Epub 2021 May 27.

PMID: 34043098 German. No abstract available.

121. Flavored Cannabis Product Use Among Adolescents in California.

Werts M, Urata J, Watkins SL, Chaffee BW.

Prev Chronic Dis. 2021 Jun 3;18:E54. doi: 10.5888/pcd18.210026.

PMID: 34081578

122. Association between age of cannabis initiation and gray matter covariance networks in recent onset psychosis.

Penzel N, Antonucci LA, Betz LT, Sanfelici R, Weiske J, Pogarell O, Cumming P, Quednow BB, Howes O, Falkai P, Upthegrove R, Bertolino A, Borgwardt S, Brambilla P, Lencer R, Meisenzahl E, Rosen M, Haidl T, Kambeitz-Ilankovic L, Ruhrmann S, Salokangas RRK, Pantelis C, Wood SJ, Koutsouleris N, Kambeitz J; PRONIA Consortium.

Neuropsychopharmacology. 2021 Jul;46(8):1484-1493. doi: 10.1038/s41386-021-00977-9. Epub 2021 Mar 3.

PMID: 33658653

123. Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow-up study.

Krämer M, Schäper M, Dücker K, Philipsen A, Losacker M, Dreimüller N, Engelmann J, Madea B, Hess C.

Drug Test Anal. 2021 Jun 11. doi: 10.1002/dta.3110. Online ahead of print.

PMID: 34114750

124. The Partners for Change Outcome Management System in the psychotherapeutic treatment of cannabis use: a pilot effectiveness randomized clinical trial.

Østergård OK, Del Palacio-Gonzalez A, Nilsson KK, Pedersen MU.

Nord J Psychiatry. 2021 Jun 21:1-8. doi: 10.1080/08039488.2021.1921265. Online ahead of print.

PMID: 34154520

125. The effect of cannabis policies on treatment outcomes for cannabis use among U.S. adults.

Bourdon JL, Francis MW, Jia L, Liang C, Robinson HI, Grucza RA.

J Subst Abuse Treat. 2021 Jun 11:108535. doi: 10.1016/j.jsat.2021.108535. Online ahead of print.

PMID: 34154870

126. Potential therapeutic uses of cannabinoids to treat behavioural problems in children and adolescents with developmental disorders.

Efron D.

Aust J Gen Pract. 2021 Jun;50(6):352-355. doi: 10.31128/AJGP-01-21-5809.

PMID: 34059838

127. Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB2 Receptor Derived from the Natural Product Cannabidiol.

Navarro G, Gonzalez A, Sánchez-Morales A, Casajuana-Martin N, Gómez-Ventura M, Cordomí A, Busqué F, Alibés R, Pardo L, Franco R.

J Med Chem. 2021 Jun 23. doi: 10.1021/acs.jmedchem.1c00561. Online ahead of print.

PMID: 34161090

128. Cannabichromene Racemization and Absolute Stereochemistry Based on a Cannabicyclol Analog.

Agua AR, Barr PJ, Marlowe CK, Pirrung MC.

J Org Chem. 2021 Jun 18;86(12):8036-8040. doi: 10.1021/acs.joc.1c00451. Epub 2021 Jun 2.

PMID: 34078070

129. Examining the differential effects of latent impulsivity factors on substance use outcomes in African American men.

Bertin L, Benca-Bachman CE, Kogan SM, Palmer RHC.

Addict Behav. 2021 Jun;117:106847. doi: 10.1016/j.addbeh.2021.106847. Epub 2021 Jan 26.

PMID: 33578106

130. Call for Special Issue Papers: Cannabidiol.

Bradshaw H.

Cannabis Cannabinoid Res. 2021 Jun;6(3):264. doi: 10.1089/can.2021.29016.cfp. Epub 2021 May 7.

PMID: 33998901 No abstract available.

131. In-depth cannabis fatty acid profiling by ultra-high performance liquid chromatography coupled to high resolution mass spectrometry.

Piovesana S, Aita SE, Cannazza G, Capriotti AL, Cavaliere C, Cerrato A, Guarnaccia P, Montone CM, Laganà A.

Talanta. 2021 Jun 1;228:122249. doi: 10.1016/j.talanta.2021.122249. Epub 2021 Feb 26.

PMID: 33773747

132. Estimating Cannabis Involvement in Fatal Crashes in Washington State Before and After Recreational Cannabis Legalization Using Multiple Imputation of Missing Values.

Tefft BC, Arnold LS.

Am J Epidemiol. 2021 Jun 22:kwab184. doi: 10.1093/aje/kwab184. Online ahead of print.

PMID: 34157068

133. Co-using drugs-what do we need to know?

Najman JM.

Addiction. 2021 Jul;116(7):1634-1635. doi: 10.1111/add.15419. Epub 2021 Feb 8.

PMID: 33559244 No abstract available.

134. Cannabis chains of influence from a US perspective.

Jernigan DH.

Addiction. 2021 Jun 9. doi: 10.1111/add.15577. Online ahead of print.

PMID: 34105204 No abstract available.

135. Editorial: Medical cannabis – Progress and promise.

Duns G.

Aust J Gen Pract. 2021 Jun;50(6):341. doi: 10.31128/AJGP-06-21-1234e.

PMID: 34059835 No abstract available.

136. Psychosocial functioning associated with prescription stimulant and opioid misuse versus illicit drug use among college students.

Kerr DCR, Bae H, Cole VT, Hussong AM.

J Am Coll Health. 2021 Jun 16:1-10. doi: 10.1080/07448481.2021.1926269. Online ahead of print.

PMID: 34133905

137. Impacts of Canada’s cannabis legalization on police-reported crime among youth: early evidence.

Callaghan RC, Vander Heiden J, Sanches M, Asbridge M, Hathaway A, Kish SJ.

Addiction. 2021 Jun 4. doi: 10.1111/add.15535. Online ahead of print.

PMID: 34085338

138. A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders.

Athanassiou M, Dumais A, Gnanhoue G, Abdel-Baki A, Jutras-Aswad D, Potvin S.

Expert Rev Neurother. 2021 Jun 21:1-13. doi: 10.1080/14737175.2021.1942845. Online ahead of print.

PMID: 34120548

139. Antifungal and anti-aflatoxigenic properties of organs of Cannabis sativa L.: relation to phenolic content and antioxidant capacities.

Al Khoury A, Sleiman R, Atoui A, Hindieh P, Maroun RG, Bailly JD, El Khoury A.

Arch Microbiol. 2021 Jun 18. doi: 10.1007/s00203-021-02444-x. Online ahead of print.

PMID: 34143269

140. A pilot randomized clinical trial of Brief Behavioral Treatment for Insomnia to reduce problematic cannabis use among trauma-exposed young adults.

Short NA, Zvolensky MJ, Schmidt NB.

J Subst Abuse Treat. 2021 Jun 16:108537. doi: 10.1016/j.jsat.2021.108537. Online ahead of print.

PMID: 34148759

141. The authors respond: “Cannabidiol-induced toxicity: Who is the culprit?”.

Berger BA, Stolz U, Colvin J, Otten EJ.

Am J Emerg Med. 2021 Jun 9:S0735-6757(21)00487-3. doi: 10.1016/j.ajem.2021.06.004. Online ahead of print.

PMID: 34147325 No abstract available.

142. Concerns about Recommendations for Perioperative Cannabis Use.

Davidson EM, Raz N, Eyal AM.

JAMA Surg. 2021 Jun 16. doi: 10.1001/jamasurg.2021.2262. Online ahead of print.

PMID: 34132761 No abstract available.

143. Experiences of Court Clinicians Who Perform Civil Commitment Evaluations for Substance Use Disorders.

Christopher PP, Pridgen BE, Pivovarova E.

J Am Acad Psychiatry Law. 2021 Jun;49(2):187-193. doi: 10.29158/JAAPL.200061-20. Epub 2021 Feb 12.

PMID: 33579732

144. Concerns about Recommendations for Perioperative Cannabis Use.

Ladha KS, McLaren-Blades A, Clarke H.

JAMA Surg. 2021 Jun 16. doi: 10.1001/jamasurg.2021.2259. Online ahead of print.

PMID: 34132769 No abstract available.

145. Concerns about Recommendations for Perioperative Cannabis Use-Reply.

Stewart C, Fong Y.

JAMA Surg. 2021 Jun 16. doi: 10.1001/jamasurg.2021.2265. Online ahead of print.

PMID: 34132757 No abstract available.

146. The endocannabinoid system as a therapeutic target for schizophrenia: failures and potentials.

Seillier A.

Neurosci Lett. 2021 Jun 16:136064. doi: 10.1016/j.neulet.2021.136064. Online ahead of print.

PMID: 34146641

147. Peri-operative care of the cannabis user: practical considerations.

Bhakta P, Karim HMR, O’Brien B.

Eur J Anaesthesiol. 2021 Jun 1;38(6):664. doi: 10.1097/EJA.0000000000001441.

PMID: 33967256 No abstract available.

148. Potential alcohol use disorder among MSM in Ireland – Findings from the European MSM internet survey (EMIS 2017).

Daly FP, O’Donnell K, Davoren MP, Noone C, Weatherburn P, Quinlan M, Foley B, Igoe D, Barrett PM.

Drug Alcohol Depend. 2021 Jun 1;223:108698. doi: 10.1016/j.drugalcdep.2021.108698. Epub 2021 Apr 14.

PMID: 33878574

149. Cannabis medical and recreational use: science beyond ethical and political issues.

Iannaccone G, Abbate A, Keen Ii L 2nd, Porto I.

Minerva Cardiol Angiol. 2021 Jun 17. doi: 10.23736/S2724-5683.21.05664-7. Online ahead of print.

PMID: 34137240 No abstract available.

150. A Rare Pediatric Case of Marijuana-Induced Reversible Cerebral Vasoconstriction Syndrome.

Bliss L, McGowan B, Rahman A.

Pediatr Neurol. 2021 Jul;120:33-35. doi: 10.1016/j.pediatrneurol.2021.03.008. Epub 2021 Mar 26.

PMID: 34000447 No abstract available.

151. PM2.5 Concentrations in a Cannabis Store with On-Site Consumption.

Murphy MB, Huang AS, Schick SF.

Environ Health Perspect. 2021 Jun;129(6):67701. doi: 10.1289/EHP8689. Epub 2021 Jun 16.

PMID: 34132612 Free PMC article. No abstract available.

152. The influence of conditioned stimuli on [11C]-(+)-PHNO PET binding in tobacco smokers after a one week abstinence.

Di Ciano P, de Wit H, Mansouri E, Houle S, Boileau I, Le Foll B.

Sci Rep. 2021 Jun 3;11(1):11667. doi: 10.1038/s41598-021-90915-y.

PMID: 34083612 Free PMC article.

153. Comment on: Cannabis use assessment and its impact on pain in rheumatologic diseases: a systematic review and meta-analysis.

Singh JA.

Rheumatology (Oxford). 2021 Jun 18;60(6):e222-e224. doi: 10.1093/rheumatology/keab112.

PMID: 33576797 No abstract available.

154. Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives.

Cox DJ, Garcia-Romeu A, Johnson MW.

Am J Drug Alcohol Abuse. 2021 Jun 5:1-11. doi: 10.1080/00952990.2021.1910830. Online ahead of print.

PMID: 34096403

155. IgE-binding and mast cell-activating capacity of the homologue of the major birch pollen allergen and profilin from Cannabis sativa.

Ebo DG, Decuyper II, Rihs HP, Mertens C, Van Gasse AL, van der Poorten MM, De Puysseleyr L, Faber MA, Hagendorens MM, Bridts CH, Sabato V, Elst J.

J Allergy Clin Immunol Pract. 2021 Jun;9(6):2509-2512.e3. doi: 10.1016/j.jaip.2021.02.012. Epub 2021 Feb 16.

PMID: 33607338 No abstract available.

156. The Effects of Acute Δ9-Tetrahydrocannabinol on Striatal Glutamatergic Function: A Proton Magnetic Resonance Spectroscopy Study.

Bloomfield MAP, Petrilli K, Lees R, Hindocha C, Beck K, Turner RJ, Onwordi EC, Rane N, Lythgoe DJ, Stone JM, Curran HV, Howes OD, Freeman TP.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Jun;6(6):660-667. doi: 10.1016/j.bpsc.2021.04.013.

PMID: 34099186

157. Genome Sequence of Paenibacillus polymyxa Strain HOB6, Isolated from Hemp Seed Oil.

Mahmoud M, Jabaji S.

Microbiol Resour Announc. 2021 Jun 3;10(22):e0034421. doi: 10.1128/MRA.00344-21. Epub 2021 Jun 3.

PMID: 34080899

158. Airways flow limitation in symptomatic adult cannabis smokers.

Vozoris NT, To TM, Ryan CM, Chow CW.

Int J Tuberc Lung Dis. 2021 Jun 1;25(6):505-507. doi: 10.5588/ijtld.21.0044.

PMID: 34049615 No abstract available.

159. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia position statement.

IASP Presidential Task Force on Cannabis and Cannabinoid Analgesia.

Pain. 2021 Jul 1;162(Suppl 1):S1-S2. doi: 10.1097/j.pain.0000000000002265.

PMID: 33729207 No abstract available.

160. Mindfulness-based relapse prevention for cannabis regular users: Preliminary outcomes of a randomized clinical trial.

Schneegans A, Bourgognon F, Albuisson E, Schwan R, Arfa M, Polli L, Moulard M, Laprévote V, Schwitzer T.

Encephale. 2021 Jun 3:S0013-7006(21)00115-9. doi: 10.1016/j.encep.2021.02.015. Online ahead of print.

PMID: 34092381

161. Letter: opioid use, early biologic discontinuation for inflammatory bowel disease and a cautionary note for the age of legalised cannabis.

Oseni E, Sultan K.

Aliment Pharmacol Ther. 2021 Jul;54(1):92-93. doi: 10.1111/apt.16387.

PMID: 34109673 No abstract available.

162. Presenting the outputs of the IASP Presidential Task Force on Cannabis and Cannabinoid Analgesia.

Rice ASC, Belton J, Arendt Nielsen L.

Pain. 2021 Jul 1;162(Suppl 1):S3-S4. doi: 10.1097/j.pain.0000000000002210.

PMID: 33729208 No abstract available.

163. The impact of antenatal cannabis use on the neonate: Time for open engagement?

Singh R, Pursley DM, Davis JM; Pediatric Policy Council.

Pediatr Res. 2021 Jun 11. doi: 10.1038/s41390-021-01591-7. Online ahead of print.

PMID: 34117358 No abstract available.

164. What cannabis can learn from Covid: Hydroxychloroquine research suggests the next step for medical cannabis research.

Caputi TL.

Int J Drug Policy. 2021 Jul;93:103133. doi: 10.1016/j.drugpo.2021.103133. Epub 2021 Jan 29.

PMID: 33517127 Free PMC article. No abstract available.

165. NewsCAP: Increased rate of calls to poison control centers for cannabis exposure among children.

[No authors listed]

Am J Nurs. 2021 Jul 1;121(7):16. doi: 10.1097/01.NAJ.0000758440.94924.c0.

PMID: 34156364 No abstract available.

166. United States oncologists’ clinical preferences regarding modes of medicinal cannabis use.

Sannes TS, Nayak MM, Tung S, Chai PR, Yusufov M, Bolcic-Jankovic D, Pirl WF, Braun IM.

Cancer Commun (Lond). 2021 Jun;41(6):528-531. doi: 10.1002/cac2.12160. Epub 2021 May 6.

PMID: 33955716 No abstract available.

167. The role of cytochrome P450 enzyme genetic variants in cannabis hyperemesis syndrome-A case report.

Kuzin M, Xepapadakos F, Scharrer I, Augsburger M, Eap CB, Schoretsanitis G.

Basic Clin Pharmacol Toxicol. 2021 Jul;129(1):82-85. doi: 10.1111/bcpt.13581. Epub 2021 Mar 27.

PMID: 33740842 No abstract available.

168. Correction to: Industrial hemp as an agricultural crop in Ghana.

Owusu NO, Arthur B, Aboagye EM.

J Cannabis Res. 2021 Jun 5;3(1):18. doi: 10.1186/s42238-021-00076-y.

PMID: 34090535 Free PMC article. No abstract available.

 

Source:  National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine

Filed under: Cannabis/Marijuana :

Back to top of page

Powered by WordPress